| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.55e-23 | 46 | 88 | 14 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 9.24e-14 | 188 | 88 | 14 | GO:0005201 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.15e-09 | 12 | 88 | 5 | GO:0048407 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 MAGI2 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 KRT77 COL27A1 CLTA SHANK3 COL1A1 COL1A2 | 5.25e-08 | 891 | 88 | 18 | GO:0005198 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | KLF16 TBX3 HIC1 KMT2D NKX6-2 BHLHE23 CEBPA RARG ERF FOXO6 HOXD4 MIXL1 ASCL5 TLX3 SKOR1 FOXI2 RELB NR5A1 NKX2-6 HMX1 CIC ZNF697 | 1.36e-07 | 1412 | 88 | 22 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | KLF16 TBX3 NKX6-2 BHLHE23 CEBPA RARG FOXO6 HOXD4 MIXL1 ASCL5 TLX3 SKOR1 FOXI2 RELB NR5A1 NKX2-6 HMX1 CIC HSF5 ZNF697 | 4.15e-06 | 1459 | 88 | 20 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | KLF16 TBX3 NKX6-2 BHLHE23 CEBPA RARG FOXO6 HOXD4 MIXL1 ASCL5 TLX3 SKOR1 FOXI2 RELB NR5A1 NKX2-6 HSF5 ZNF697 | 6.61e-06 | 1244 | 88 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | KLF16 TBX3 NKX6-2 BHLHE23 CEBPA RARG FOXO6 HOXD4 MIXL1 ASCL5 TLX3 SKOR1 FOXI2 RELB NR5A1 NKX2-6 HSF5 ZNF697 | 8.88e-06 | 1271 | 88 | 18 | GO:0000987 |
| GeneOntologyMolecularFunction | SMAD binding | 3.90e-05 | 86 | 88 | 5 | GO:0046332 | |
| GeneOntologyMolecularFunction | growth factor binding | 6.60e-05 | 156 | 88 | 6 | GO:0019838 | |
| GeneOntologyMolecularFunction | transcription factor binding | 4.64e-04 | 753 | 88 | 11 | GO:0008134 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 5.32e-04 | 320 | 88 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 5.94e-04 | 326 | 88 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 7.63e-04 | 93 | 88 | 4 | GO:0097110 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 1.03e-03 | 11 | 88 | 2 | GO:0098919 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.05e-03 | 582 | 88 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 1.45e-03 | 13 | 88 | 2 | GO:0098879 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.45e-03 | 417 | 88 | 7 | GO:0061629 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL27A1 MMP27 COL1A1 COL1A2 | 5.04e-10 | 377 | 86 | 14 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL27A1 MMP27 COL1A1 COL1A2 | 5.21e-10 | 378 | 86 | 14 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL27A1 MMP27 COL1A1 COL1A2 | 5.39e-10 | 379 | 86 | 14 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 2.96e-08 | 76 | 86 | 7 | GO:0030199 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.36e-07 | 12 | 86 | 4 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 8.24e-07 | 18 | 86 | 4 | GO:0038065 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 9.59e-07 | 79 | 86 | 6 | GO:0060350 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 1.50e-06 | 47 | 86 | 5 | GO:0060351 | |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 4.96e-06 | 161 | 86 | 7 | GO:0071230 | |
| GeneOntologyBiologicalProcess | growth plate cartilage chondrocyte development | 8.22e-06 | 10 | 86 | 3 | GO:0003431 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 9.24e-06 | 177 | 86 | 7 | GO:0071229 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 1.33e-05 | 124 | 86 | 6 | GO:0060349 | |
| GeneOntologyBiologicalProcess | chondrocyte development involved in endochondral bone morphogenesis | 1.94e-05 | 13 | 86 | 3 | GO:0003433 | |
| GeneOntologyBiologicalProcess | response to amino acid | 2.18e-05 | 202 | 86 | 7 | GO:0043200 | |
| GeneOntologyBiologicalProcess | growth plate cartilage chondrocyte differentiation | 2.46e-05 | 14 | 86 | 3 | GO:0003418 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 4.71e-05 | 228 | 86 | 7 | GO:0001101 | |
| GeneOntologyBiologicalProcess | skeletal system development | COL2A1 COL3A1 TSKU COL5A2 COL6A1 TBX3 RARG HOXD4 COL27A1 COL1A1 COL1A2 | 4.88e-05 | 615 | 86 | 11 | GO:0001501 |
| GeneOntologyBiologicalProcess | cartilage development | 7.04e-05 | 243 | 86 | 7 | GO:0051216 | |
| GeneOntologyBiologicalProcess | chondrocyte differentiation involved in endochondral bone morphogenesis | 7.58e-05 | 20 | 86 | 3 | GO:0003413 | |
| GeneOntologyBiologicalProcess | bone development | 1.18e-04 | 264 | 86 | 7 | GO:0060348 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | TSKU COL4A2 COL4A3 COL5A2 TBX3 NKX6-2 BHLHE23 CEBPA RARG MIXL1 TLX3 ADGRB1 NR5A1 TMEM64 NOTCH3 | 1.44e-04 | 1220 | 86 | 15 | GO:0051093 |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 1.59e-04 | 277 | 86 | 7 | GO:0048705 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TBX3 KMT2D PAXBP1 BHLHE23 CEBPA RARG HOXD4 MIXL1 ASCL5 FIZ1 RELB NR5A1 NKX2-6 TAF4 NOTCH3 CRTC2 | 1.79e-04 | 1390 | 86 | 16 | GO:0045944 |
| GeneOntologyBiologicalProcess | tube development | COL2A1 COL3A1 COL4A2 COL4A3 COL6A1 TBX3 CEBPA RARG MIXL1 COL27A1 ADGRB1 KCNQ1 NKX2-6 SHANK3 CIC NOTCH3 | 1.98e-04 | 1402 | 86 | 16 | GO:0035295 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | COL2A1 COL3A1 TSKU COL5A2 COL6A1 TBX3 BHLHE23 RARG HOXD4 COL27A1 ASCL5 KCNQ1 SHANK3 COL1A1 COL1A2 | 2.21e-04 | 1269 | 86 | 15 | GO:0009887 |
| GeneOntologyBiologicalProcess | growth plate cartilage development | 2.36e-04 | 29 | 86 | 3 | GO:0003417 | |
| GeneOntologyBiologicalProcess | chondrocyte differentiation | 2.37e-04 | 133 | 86 | 5 | GO:0002062 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | MAGI2 COL6A1 TBX3 NKX6-2 CEBPA RARG KRT77 COL27A1 ASCL5 KCNQ1 NR5A1 NKX2-6 | 2.54e-04 | 870 | 86 | 12 | GO:0030855 |
| GeneOntologyBiologicalProcess | embryo development | COL2A1 COL3A1 COL5A2 TBX3 KMT2D CEBPA RARG ERF HOXD4 MIXL1 COL27A1 KCNQ1 NKX2-6 NXN SHANK3 COL1A1 | 2.62e-04 | 1437 | 86 | 16 | GO:0009790 |
| GeneOntologyBiologicalProcess | circulatory system development | COL2A1 COL3A1 COL4A2 COL4A3 COL6A1 PRICKLE4 TBX3 MIXL1 COL27A1 ADGRB1 KCNQ1 NKX2-6 NXN NOTCH3 COL1A1 COL1A2 | 2.72e-04 | 1442 | 86 | 16 | GO:0072359 |
| GeneOntologyBiologicalProcess | glomerulus development | 3.02e-04 | 77 | 86 | 4 | GO:0032835 | |
| GeneOntologyBiologicalProcess | limb joint morphogenesis | 3.56e-04 | 7 | 86 | 2 | GO:0036022 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | KLF16 TBX3 HIC1 NKX6-2 CEBPA RARG ERF ASCL5 SKOR1 HMX1 AJUBA CIC NOTCH3 | 4.04e-04 | 1053 | 86 | 13 | GO:0000122 |
| GeneOntologyBiologicalProcess | embryonic organ development | 5.47e-04 | 561 | 86 | 9 | GO:0048568 | |
| GeneOntologyBiologicalProcess | neuron fate commitment | 5.71e-04 | 91 | 86 | 4 | GO:0048663 | |
| GeneOntologyBiologicalProcess | endochondral bone growth | 5.74e-04 | 39 | 86 | 3 | GO:0003416 | |
| GeneOntologyBiologicalProcess | connective tissue development | 5.77e-04 | 343 | 86 | 7 | GO:0061448 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 5.77e-04 | 343 | 86 | 7 | GO:0090596 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | KLF16 TBX3 HIC1 NKX6-2 CEBPA RARG ERF ASCL5 SKOR1 RELB HMX1 AJUBA CIC NOTCH3 HR | 6.21e-04 | 1399 | 86 | 15 | GO:0045892 |
| GeneOntologyBiologicalProcess | chondrocyte development | 6.65e-04 | 41 | 86 | 3 | GO:0002063 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | KLF16 TBX3 HIC1 NKX6-2 CEBPA RARG ERF ASCL5 SKOR1 RELB HMX1 AJUBA CIC NOTCH3 HR | 6.89e-04 | 1413 | 86 | 15 | GO:1902679 |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 7.57e-04 | 10 | 86 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | bone growth | 8.75e-04 | 45 | 86 | 3 | GO:0098868 | |
| GeneOntologyBiologicalProcess | epithelium development | COL2A1 MAGI2 COL6A1 TBX3 NKX6-2 CEBPA RARG KRT77 COL27A1 ASCL5 KCNQ1 NR5A1 NKX2-6 AJUBA SHANK3 | 1.02e-03 | 1469 | 86 | 15 | GO:0060429 |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 1.06e-03 | 185 | 86 | 5 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 1.06e-03 | 185 | 86 | 5 | GO:0035108 | |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 MARCO COL1A1 COL1A2 | 1.64e-20 | 88 | 88 | 15 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL27A1 COL1A1 COL1A2 | 3.50e-19 | 21 | 88 | 10 | GO:0098644 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 4.24e-12 | 12 | 88 | 6 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 4.24e-12 | 12 | 88 | 6 | GO:0098643 | |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL3A1 TSKU COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 SSC5D FCGBP COL16A1 COL21A1 COL27A1 MMP27 MARCO COL1A1 COL1A2 | 2.49e-11 | 656 | 88 | 19 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL3A1 TSKU COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 SSC5D FCGBP COL16A1 COL21A1 COL27A1 MMP27 MARCO COL1A1 COL1A2 | 2.62e-11 | 658 | 88 | 19 | GO:0030312 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.10e-10 | 332 | 88 | 14 | GO:0005788 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 SSC5D COL16A1 COL21A1 COL27A1 MARCO COL1A1 COL1A2 | 6.27e-10 | 530 | 88 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | collagen type IV trimer | 4.37e-09 | 6 | 88 | 4 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 2.03e-08 | 8 | 88 | 4 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.03e-08 | 8 | 88 | 4 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.03e-08 | 8 | 88 | 4 | GO:0098645 | |
| GeneOntologyCellularComponent | chromatin | KLF16 TBX3 HIC1 NKX6-2 BHLHE23 CEBPA RARG ERF FOXO6 HOXD4 MIXL1 ASCL5 FIZ1 TLX3 FOXI2 SMARCD2 RELB NR5A1 NKX2-6 TAF4 HMX1 CIC HR | 2.97e-08 | 1480 | 88 | 23 | GO:0000785 |
| GeneOntologyCellularComponent | basement membrane | 1.28e-05 | 122 | 88 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen type I trimer | 1.75e-05 | 2 | 88 | 2 | GO:0005584 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.74e-04 | 5 | 88 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 PRICKLE4 SLC8A2 KRT77 COL27A1 COL1A1 COL1A2 | 4.19e-04 | 1187 | 88 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | transcription regulator complex | 9.05e-04 | 596 | 88 | 9 | GO:0005667 | |
| HumanPheno | Arterial rupture | 2.23e-07 | 8 | 40 | 4 | HP:0025019 | |
| HumanPheno | Hypermobility of distal interphalangeal joints | 4.49e-07 | 3 | 40 | 3 | HP:0006201 | |
| HumanPheno | Cigarette-paper scars | 6.62e-07 | 10 | 40 | 4 | HP:0001073 | |
| HumanPheno | Cervical insufficiency | 1.79e-06 | 4 | 40 | 3 | HP:0030009 | |
| HumanPheno | Hypermobility of interphalangeal joints | 4.44e-06 | 5 | 40 | 3 | HP:0005620 | |
| HumanPheno | Platybasia | 7.21e-06 | 17 | 40 | 4 | HP:0002691 | |
| HumanPheno | Atrophic scars | 8.37e-06 | 37 | 40 | 5 | HP:0001075 | |
| HumanPheno | Molluscoid pseudotumors | 1.54e-05 | 7 | 40 | 3 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 1.54e-05 | 7 | 40 | 3 | HP:0000139 | |
| HumanPheno | Inguinal hernia | COL2A1 COL3A1 COL5A2 TBX3 KMT2D ARVCF TAF4 NXN NOTCH3 COL1A1 COL1A2 | 1.77e-05 | 312 | 40 | 11 | HP:0000023 |
| HumanPheno | Atypical scarring of skin | 1.99e-05 | 74 | 40 | 6 | HP:0000987 | |
| HumanPheno | Genital hernia | 2.45e-05 | 8 | 40 | 3 | HP:0100823 | |
| HumanPheno | Biconcave vertebral bodies | 3.66e-05 | 25 | 40 | 4 | HP:0004586 | |
| HumanPheno | Congenital hip dislocation | 4.12e-05 | 84 | 40 | 6 | HP:0001374 | |
| HumanPheno | Localized skin lesion | COL2A1 COL3A1 COL5A2 COL6A1 HIC1 KMT2D ERF ARVCF KCNQ1 SLC39A4 NKX2-6 TAF4 NXN SHANK3 TOP3A NOTCH3 COL1A1 COL1A2 | 5.16e-05 | 897 | 40 | 18 | HP:0011355 |
| HumanPheno | Lenticonus | 5.18e-05 | 10 | 40 | 3 | HP:0001142 | |
| HumanPheno | Biconcave flattened vertebrae | 6.01e-05 | 2 | 40 | 2 | HP:0003321 | |
| HumanPheno | Absent ossification of calvaria | 6.01e-05 | 2 | 40 | 2 | HP:0005623 | |
| HumanPheno | Severe generalized osteoporosis | 6.01e-05 | 2 | 40 | 2 | HP:0005897 | |
| HumanPheno | Femoral bowing present at birth, straightening with time | 6.01e-05 | 2 | 40 | 2 | HP:0005005 | |
| HumanPheno | Hernia of the abdominal wall | COL2A1 COL3A1 COL5A2 TBX3 HIC1 KMT2D ARVCF KCNQ1 TAF4 NXN NOTCH3 COL1A1 COL1A2 | 7.59e-05 | 506 | 40 | 13 | HP:0004299 |
| HumanPheno | Abdominal wall defect | COL2A1 COL3A1 COL5A2 TBX3 HIC1 KMT2D ARVCF KCNQ1 TAF4 NXN NOTCH3 COL1A1 COL1A2 | 8.41e-05 | 511 | 40 | 13 | HP:0010866 |
| HumanPheno | Thoracoabdominal wall defect | COL2A1 COL3A1 COL5A2 TBX3 HIC1 KMT2D ARVCF KCNQ1 TAF4 NXN NOTCH3 COL1A1 COL1A2 | 8.41e-05 | 511 | 40 | 13 | HP:0100656 |
| HumanPheno | Arterial dissection | 9.40e-05 | 12 | 40 | 3 | HP:0005294 | |
| HumanPheno | Arteriovenous fistula | 9.40e-05 | 12 | 40 | 3 | HP:0004947 | |
| HumanPheno | Abnormal uterine cervix morphology | 1.22e-04 | 13 | 40 | 3 | HP:0012888 | |
| HumanPheno | Lower extremity joint dislocation | COL2A1 COL3A1 COL5A2 COL6A1 KMT2D ARVCF COL27A1 ECEL1 COL1A1 COL1A2 | 1.23e-04 | 318 | 40 | 10 | HP:0030311 |
| HumanPheno | Scarring | 1.23e-04 | 102 | 40 | 6 | HP:0100699 | |
| HumanPheno | Joint dislocation | COL2A1 COL3A1 COL5A2 COL6A1 KMT2D ARVCF COL27A1 ECEL1 NXN COL1A1 COL1A2 | 1.39e-04 | 390 | 40 | 11 | HP:0001373 |
| HumanPheno | Slender build | 1.45e-04 | 66 | 40 | 5 | HP:0001533 | |
| HumanPheno | Hip dislocation | COL2A1 COL3A1 COL5A2 COL6A1 KMT2D COL27A1 ECEL1 COL1A1 COL1A2 | 1.51e-04 | 263 | 40 | 9 | HP:0002827 |
| HumanPheno | Recurrent joint dislocation | 1.54e-04 | 14 | 40 | 3 | HP:0031869 | |
| HumanPheno | Neonatal short-limb short stature | 1.54e-04 | 14 | 40 | 3 | HP:0008921 | |
| HumanPheno | Soft, doughy skin | 1.54e-04 | 14 | 40 | 3 | HP:0001027 | |
| HumanPheno | Bladder diverticulum | 1.60e-04 | 36 | 40 | 4 | HP:0000015 | |
| HumanPheno | Fragile skin | 1.79e-04 | 37 | 40 | 4 | HP:0001030 | |
| HumanPheno | Small joint hypermobilty | 1.79e-04 | 69 | 40 | 5 | HP:0430046 | |
| HumanPheno | Glomerular basement membrane lamellation | 1.79e-04 | 3 | 40 | 2 | HP:0030034 | |
| HumanPheno | Anterior lenticonus | 1.79e-04 | 3 | 40 | 2 | HP:0011501 | |
| HumanPheno | Popcorn calcification | 1.79e-04 | 3 | 40 | 2 | HP:6000871 | |
| HumanPheno | Subcutaneous spheroids | 1.79e-04 | 3 | 40 | 2 | HP:0025014 | |
| HumanPheno | Thin glomerular basement membrane | 1.79e-04 | 3 | 40 | 2 | HP:0012577 | |
| HumanPheno | Abnormal toe morphology | COL2A1 COL3A1 COL6A1 TBX3 KMT2D ERF ARVCF PEX6 SMARCD2 NR5A1 NKX2-6 TAF4 NXN SHANK3 CIC COL1A1 COL1A2 | 1.87e-04 | 893 | 40 | 17 | HP:0001780 |
| HumanPheno | Muscle flaccidity | 1.91e-04 | 15 | 40 | 3 | HP:0010547 | |
| HumanPheno | Abnormality of the abdominal wall | COL2A1 COL3A1 COL5A2 TBX3 HIC1 KMT2D ARVCF KCNQ1 TAF4 NXN NOTCH3 COL1A1 COL1A2 | 2.16e-04 | 560 | 40 | 13 | HP:0004298 |
| HumanPheno | Abnormality of the elbow | 2.57e-04 | 282 | 40 | 9 | HP:0009811 | |
| HumanPheno | Abnormal sacrum morphology | 2.68e-04 | 167 | 40 | 7 | HP:0005107 | |
| HumanPheno | Abnormal atrioventricular valve morphology | COL2A1 COL3A1 COL5A2 KMT2D ARVCF POLG NKX2-6 NXN COL1A1 COL1A2 | 2.71e-04 | 350 | 40 | 10 | HP:0006705 |
| HumanPheno | Premature rupture of membranes | 2.83e-04 | 17 | 40 | 3 | HP:0001788 | |
| HumanPheno | Tall stature | 2.89e-04 | 225 | 40 | 8 | HP:0000098 | |
| HumanPheno | Abnormality of lens shape | 3.37e-04 | 18 | 40 | 3 | HP:0011526 | |
| HumanPheno | Mitral valve prolapse | 3.44e-04 | 123 | 40 | 6 | HP:0001634 | |
| HumanPheno | Piezogenic pedal papules | 3.57e-04 | 4 | 40 | 2 | HP:0025509 | |
| HumanPheno | Bowing of limbs due to multiple fractures | 3.57e-04 | 4 | 40 | 2 | HP:0003023 | |
| HumanPheno | Incisional hernia | 3.57e-04 | 4 | 40 | 2 | HP:0004872 | |
| HumanPheno | Hernia | COL2A1 COL3A1 COL5A2 TBX3 HIC1 KMT2D ARVCF KCNQ1 TAF4 NXN NOTCH3 COL1A1 COL1A2 | 3.58e-04 | 589 | 40 | 13 | HP:0100790 |
| HumanPheno | Short limb dwarfism | 3.98e-04 | 19 | 40 | 3 | HP:0003505 | |
| HumanPheno | Shoulder dislocation | 4.66e-04 | 20 | 40 | 3 | HP:0003834 | |
| HumanPheno | Generalized osteoporosis | 4.66e-04 | 20 | 40 | 3 | HP:0040160 | |
| HumanPheno | Chiari type I malformation | 4.95e-04 | 48 | 40 | 4 | HP:0007099 | |
| HumanPheno | Abnormality of habitus | 5.32e-04 | 87 | 40 | 5 | HP:0010718 | |
| HumanPheno | Dwarfism | 5.41e-04 | 21 | 40 | 3 | HP:0001516 | |
| HumanPheno | Hip dysplasia | 5.43e-04 | 247 | 40 | 8 | HP:0001385 | |
| HumanPheno | Abnormal finger morphology | COL2A1 COL3A1 COL5A2 COL6A1 TBX3 HIC1 KMT2D ERF ARVCF COL27A1 PEX6 SLC39A4 ECEL1 NR5A1 NKX2-6 TAF4 NXN SHANK3 CIC COL1A1 COL1A2 | 5.78e-04 | 1385 | 40 | 21 | HP:0001167 |
| HumanPheno | Basilar impression | 5.92e-04 | 5 | 40 | 2 | HP:0005758 | |
| HumanPheno | Aplasia/Hypoplasia of the 4th finger | 5.92e-04 | 5 | 40 | 2 | HP:0009272 | |
| HumanPheno | Abnormal middle ear morphology | COL2A1 KMT2D ARVCF SMARCD2 RELB TAF4 NXN NOTCH3 COL1A1 COL1A2 | 6.48e-04 | 390 | 40 | 10 | HP:0008609 |
| HumanPheno | Finger joint hypermobility | 6.73e-04 | 52 | 40 | 4 | HP:0006094 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 7.24e-04 | 53 | 40 | 4 | HP:0009906 | |
| HumanPheno | Abnormal pulmonary valve morphology | 7.54e-04 | 198 | 40 | 7 | HP:0001641 | |
| HumanPheno | Convex nasal ridge | 7.97e-04 | 95 | 40 | 5 | HP:0000444 | |
| HumanPheno | Abnormal aortic morphology | COL3A1 COL5A2 KMT2D ARVCF NKX2-6 TAF4 NXN NOTCH3 COL1A1 COL1A2 | 8.07e-04 | 401 | 40 | 10 | HP:0001679 |
| HumanPheno | Joint hypermobility | COL2A1 COL3A1 COL5A2 COL6A1 KMT2D ARVCF ECEL1 TAF4 SHANK3 NOTCH3 COL1A1 COL1A2 | 8.11e-04 | 557 | 40 | 12 | HP:0001382 |
| HumanPheno | Joint laxity | 8.33e-04 | 55 | 40 | 4 | HP:0001388 | |
| HumanPheno | Upper extremity joint dislocation | 8.36e-04 | 96 | 40 | 5 | HP:0030310 | |
| HumanPheno | Abnormal mitral valve morphology | 8.58e-04 | 146 | 40 | 6 | HP:0031477 | |
| HumanPheno | Abnormal external nose morphology | COL2A1 COL3A1 HIC1 KMT2D NKX6-2 ERF ARVCF COL27A1 PEX6 ECEL1 TAF4 NXN SHANK3 NOVA2 COL1A1 COL1A2 | 8.74e-04 | 916 | 40 | 16 | HP:0010938 |
| HumanPheno | Crumpled long bones | 8.84e-04 | 6 | 40 | 2 | HP:0006367 | |
| HumanPheno | Abnormality of the middle ear ossicles | 9.15e-04 | 25 | 40 | 3 | HP:0004452 | |
| HumanPheno | Abnormality of hand joint mobility | 9.54e-04 | 57 | 40 | 4 | HP:0006256 | |
| HumanPheno | Abnormal 3rd finger morphology | 1.03e-03 | 26 | 40 | 3 | HP:0004150 | |
| HumanPheno | Abnormal testis morphology | COL2A1 COL3A1 COL5A2 TBX3 KMT2D ARVCF POLG PEX6 KCNQ1 SLC39A4 NR5A1 NKX2-6 TAF4 NXN NANOS1 NOTCH3 COL1A1 COL1A2 | 1.07e-03 | 1129 | 40 | 18 | HP:0000035 |
| HumanPheno | Non-obstructive azoospermia | COL2A1 COL3A1 COL5A2 TBX3 KMT2D ARVCF POLG PEX6 KCNQ1 SLC39A4 NR5A1 NKX2-6 TAF4 NXN NANOS1 NOTCH3 COL1A1 COL1A2 | 1.10e-03 | 1132 | 40 | 18 | HP:0011961 |
| HumanPheno | Tooth malposition | COL3A1 KMT2D NKX6-2 PEX6 SMARCD2 TAF4 NXN SHANK3 NOTCH3 COL1A2 | 1.12e-03 | 418 | 40 | 10 | HP:0000692 |
| HumanPheno | Abnormal hallux morphology | 1.13e-03 | 212 | 40 | 7 | HP:0001844 | |
| HumanPheno | Dermal translucency | 1.15e-03 | 27 | 40 | 3 | HP:0010648 | |
| HumanPheno | Ptosis | COL2A1 COL3A1 KMT2D ERF ARVCF POLG PEX6 ECEL1 NXN SHANK3 TOP3A NOTCH3 NOVA2 COL1A2 | 1.17e-03 | 754 | 40 | 14 | HP:0000508 |
| HumanPheno | Pulp calcification | 1.23e-03 | 7 | 40 | 2 | HP:0003771 | |
| HumanPheno | Otosclerosis | 1.23e-03 | 7 | 40 | 2 | HP:0000362 | |
| HumanPheno | Phalangeal dislocation | 1.23e-03 | 7 | 40 | 2 | HP:0006243 | |
| HumanPheno | Aplasia/Hypoplasia of the 3rd finger | 1.23e-03 | 7 | 40 | 2 | HP:0009318 | |
| HumanPheno | Increased inflammatory response | COL2A1 COL3A1 COL4A3 COL4A4 MAGI2 COL4A6 COL5A2 COL6A1 KMT2D ERF ARVCF POLG SMARCD2 SLC39A4 RELB TAF4 NXN CIC TOP3A HR | 1.28e-03 | 1355 | 40 | 20 | HP:0012649 |
| HumanPheno | Abnormal inflammatory response | COL2A1 COL3A1 COL4A3 COL4A4 MAGI2 COL4A6 COL5A2 COL6A1 KMT2D ERF ARVCF POLG SMARCD2 SLC39A4 RELB TAF4 NXN CIC TOP3A HR | 1.28e-03 | 1355 | 40 | 20 | HP:0012647 |
| HumanPheno | Periorbital edema | 1.31e-03 | 106 | 40 | 5 | HP:0100539 | |
| HumanPheno | Abnormal heart valve morphology | COL2A1 COL3A1 COL5A2 KMT2D ARVCF POLG NKX2-6 NXN CIC NOTCH3 COL1A1 COL1A2 | 1.32e-03 | 588 | 40 | 12 | HP:0001654 |
| HumanPheno | Anterior bulging of the globe | 1.33e-03 | 283 | 40 | 8 | HP:0000644 | |
| HumanPheno | Proptosis | 1.33e-03 | 283 | 40 | 8 | HP:0000520 | |
| HumanPheno | Slender finger | 1.34e-03 | 159 | 40 | 6 | HP:0001238 | |
| HumanPheno | Dermal atrophy | 1.36e-03 | 107 | 40 | 5 | HP:0004334 | |
| HumanPheno | Arteriovenous malformation | 1.42e-03 | 108 | 40 | 5 | HP:0100026 | |
| MousePheno | thick dermal layer | 6.40e-06 | 22 | 79 | 4 | MP:0001245 | |
| MousePheno | increased QRS amplitude | 3.15e-05 | 2 | 79 | 2 | MP:0010634 | |
| MousePheno | abnormal dermal layer morphology | 3.25e-05 | 108 | 79 | 6 | MP:0001243 | |
| MousePheno | decreased circulating amylase level | 5.42e-05 | 37 | 79 | 4 | MP:0008805 | |
| MousePheno | abnormal ear morphology | COL4A2 COL4A3 HIC1 KMT2D POLG KCNQ1 HMX1 NXN SHANK3 COL1A1 HR | 6.33e-05 | 470 | 79 | 11 | MP:0002102 |
| MousePheno | abnormal osteocyte morphology | 7.53e-05 | 15 | 79 | 3 | MP:0008753 | |
| MousePheno | abnormal osteocyte lacunocanalicular system morphology | 1.33e-04 | 18 | 79 | 3 | MP:0030485 | |
| MousePheno | decreased circulating protein level | COL4A2 COL4A3 COL4A4 KLF16 CEBPA COL16A1 NFKBIB ADGRB1 RELB ZCCHC3 COL1A1 HR COL1A2 | 1.34e-04 | 698 | 79 | 13 | MP:0014502 |
| MousePheno | hearing/vestibular/ear phenotype | COL2A1 COL4A2 COL4A3 COL4A4 HIC1 CBLN3 KMT2D POLG KCNQ1 HMX1 NXN SHANK3 NOTCH3 COL1A1 HR | 1.42e-04 | 905 | 79 | 15 | MP:0005377 |
| MousePheno | glomerular crescent | 1.58e-04 | 19 | 79 | 3 | MP:0011506 | |
| MousePheno | skin lesions | 1.61e-04 | 91 | 79 | 5 | MP:0001212 | |
| Domain | Collagen | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 MARCO COL1A1 COL1A2 | 4.11e-20 | 85 | 87 | 15 | IPR008160 |
| Domain | Collagen | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 MARCO COL1A1 COL1A2 | 4.11e-20 | 85 | 87 | 15 | PF01391 |
| Domain | Fib_collagen_C | 1.21e-14 | 11 | 87 | 7 | IPR000885 | |
| Domain | COLFI | 1.21e-14 | 11 | 87 | 7 | PF01410 | |
| Domain | NC1_FIB | 1.21e-14 | 11 | 87 | 7 | PS51461 | |
| Domain | Fib_collagen_C | 1.21e-14 | 11 | 87 | 7 | PD002078 | |
| Domain | COLFI | 1.21e-14 | 11 | 87 | 7 | SM00038 | |
| Domain | C4 | 6.54e-09 | 6 | 87 | 4 | SM00111 | |
| Domain | - | 6.54e-09 | 6 | 87 | 4 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 6.54e-09 | 6 | 87 | 4 | IPR001442 | |
| Domain | C4 | 6.54e-09 | 6 | 87 | 4 | PF01413 | |
| Domain | NC1_IV | 6.54e-09 | 6 | 87 | 4 | PS51403 | |
| Domain | VWC | 8.68e-07 | 38 | 87 | 5 | SM00214 | |
| Domain | VWF_dom | 1.45e-06 | 42 | 87 | 5 | IPR001007 | |
| Domain | TSPN | 3.63e-06 | 23 | 87 | 4 | SM00210 | |
| Domain | VWC | 8.26e-06 | 28 | 87 | 4 | PF00093 | |
| Domain | VWFC_1 | 2.31e-05 | 36 | 87 | 4 | PS01208 | |
| Domain | VWFC_2 | 2.87e-05 | 38 | 87 | 4 | PS50184 | |
| Domain | Homeobox_metazoa | 6.29e-05 | 90 | 87 | 5 | IPR020479 | |
| Domain | Laminin_G | 1.54e-04 | 58 | 87 | 4 | IPR001791 | |
| Domain | Homeobox_CS | 2.33e-04 | 186 | 87 | 6 | IPR017970 | |
| Domain | Homeobox | 7.86e-04 | 234 | 87 | 6 | PF00046 | |
| Domain | HOMEOBOX_1 | 8.22e-04 | 236 | 87 | 6 | PS00027 | |
| Domain | HOX | 8.40e-04 | 237 | 87 | 6 | SM00389 | |
| Domain | HOMEOBOX_2 | 8.78e-04 | 239 | 87 | 6 | PS50071 | |
| Domain | Homeobox_dom | 8.78e-04 | 239 | 87 | 6 | IPR001356 | |
| Domain | CTDL_fold | 1.57e-03 | 107 | 87 | 4 | IPR016187 | |
| Domain | - | 2.08e-03 | 283 | 87 | 6 | 1.10.10.60 | |
| Domain | SRCR | 4.25e-03 | 21 | 87 | 2 | PF00530 | |
| Domain | Homeodomain-like | 4.56e-03 | 332 | 87 | 6 | IPR009057 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 3.57e-23 | 44 | 64 | 14 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 2.82e-20 | 67 | 64 | 14 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 2.41e-18 | 90 | 64 | 14 | M631 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL16A1 COL1A1 COL1A2 | 1.94e-17 | 41 | 64 | 11 | MM15538 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL27A1 COL1A1 COL1A2 | 3.78e-17 | 61 | 64 | 12 | M27103 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL16A1 COL1A1 COL1A2 | 2.40e-15 | 61 | 64 | 11 | MM14637 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL16A1 COL1A1 COL1A2 | 4.22e-15 | 64 | 64 | 11 | M26953 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL2A1 COL3A1 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL16A1 COL1A1 COL1A2 | 6.40e-15 | 46 | 64 | 10 | M198 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL1A1 COL1A2 | 1.18e-14 | 32 | 64 | 9 | MM14924 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL1A1 COL1A2 | 1.59e-14 | 50 | 64 | 10 | MM14796 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL1A1 COL1A2 | 2.99e-14 | 53 | 64 | 10 | MM14566 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL16A1 COL1A1 COL1A2 | 3.12e-14 | 76 | 64 | 11 | MM14867 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL16A1 COL1A1 COL1A2 | 3.12e-14 | 76 | 64 | 11 | MM14573 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL16A1 COL1A1 COL1A2 | 1.13e-13 | 85 | 64 | 11 | M16441 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL2A1 COL3A1 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL16A1 COL1A1 COL1A2 | 1.02e-12 | 74 | 64 | 10 | M160 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL1A1 COL1A2 | 1.35e-12 | 76 | 64 | 10 | M27219 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.10e-12 | 20 | 64 | 7 | MM15061 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL1A1 COL1A2 | 4.80e-12 | 59 | 64 | 9 | M27218 |
| Pathway | PID_INTEGRIN1_PATHWAY | COL2A1 COL3A1 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL1A1 COL1A2 | 1.38e-11 | 66 | 64 | 9 | M18 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL16A1 COL1A1 COL1A2 | 2.96e-11 | 140 | 64 | 11 | M587 |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 3.34e-11 | 15 | 64 | 6 | M27161 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 5.32e-11 | 300 | 64 | 14 | M610 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.32e-11 | 30 | 64 | 7 | M27772 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL1A1 COL1A2 | 8.42e-11 | 114 | 64 | 10 | MM14571 |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.23e-10 | 18 | 64 | 6 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.23e-10 | 18 | 64 | 6 | MM14882 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | COL2A1 COL3A1 COL4A2 COL4A4 COL4A6 COL5A2 COL6A1 COL1A1 COL1A2 | 1.29e-10 | 84 | 64 | 9 | M7098 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.20e-10 | 38 | 64 | 7 | MM14969 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.65e-10 | 41 | 64 | 7 | M27778 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 6.75e-10 | 42 | 64 | 7 | M7169 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 6.28e-09 | 57 | 64 | 7 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 7.11e-09 | 58 | 64 | 7 | M2049 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.29e-08 | 63 | 64 | 7 | M11187 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.82e-08 | 19 | 64 | 5 | MM15512 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.82e-08 | 19 | 64 | 5 | M27221 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL16A1 COL1A1 COL1A2 | 1.97e-08 | 258 | 64 | 11 | MM14572 |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.36e-08 | 79 | 64 | 7 | M27643 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.40e-08 | 47 | 64 | 6 | MM14925 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 7.95e-08 | 10 | 64 | 4 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 7.95e-08 | 10 | 64 | 4 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.24e-07 | 11 | 64 | 4 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.86e-07 | 12 | 64 | 4 | MM1526 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.15e-07 | 30 | 64 | 5 | MM15517 | |
| Pathway | KEGG_FOCAL_ADHESION | COL2A1 COL3A1 COL4A2 COL4A4 COL4A6 COL5A2 COL6A1 COL1A1 COL1A2 | 2.62e-07 | 199 | 64 | 9 | M7253 |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.68e-07 | 13 | 64 | 4 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.68e-07 | 13 | 64 | 4 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.74e-07 | 14 | 64 | 4 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.74e-07 | 14 | 64 | 4 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.08e-07 | 15 | 64 | 4 | MM14922 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.39e-06 | 43 | 64 | 5 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.39e-06 | 43 | 64 | 5 | M53 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.77e-06 | 20 | 64 | 4 | M15394 | |
| Pathway | WP_FOCAL_ADHESION | 1.94e-06 | 187 | 64 | 8 | MM15913 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL5A2 COL6A1 TBX3 CEBPA KRT77 CLTA SHANK3 | 2.22e-06 | 502 | 64 | 12 | MM14537 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL5A2 COL6A1 CLTA SHANK3 | 2.52e-06 | 261 | 64 | 9 | MM15676 |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 3.21e-06 | 23 | 64 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 3.21e-06 | 23 | 64 | 4 | MM1427 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL5A2 COL6A1 COL24A1 COL27A1 CLTA COL1A1 COL1A2 | 4.04e-06 | 532 | 64 | 12 | M27870 |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 5.24e-06 | 98 | 64 | 6 | M27152 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 6.27e-06 | 27 | 64 | 4 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 7.29e-06 | 28 | 64 | 4 | MM15957 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | COL2A1 COL3A1 COL4A2 COL4A4 COL4A6 COL5A2 CRTC2 COL1A1 COL1A2 | 8.26e-06 | 302 | 64 | 9 | M39719 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 9.69e-06 | 30 | 64 | 4 | M27216 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.28e-05 | 67 | 64 | 5 | MM15345 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | COL2A1 COL3A1 COL4A2 COL4A4 COL4A6 COL5A2 CRTC2 COL1A1 COL1A2 | 1.52e-05 | 326 | 64 | 9 | MM15917 |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL5A2 COL6A1 CLTA COL1A1 COL1A2 | 1.71e-05 | 418 | 64 | 10 | MM15587 |
| Pathway | WP_FOCAL_ADHESION | 3.16e-05 | 199 | 64 | 7 | M39402 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL5A2 COL6A1 TBX3 KMT2D CEBPA RARG HOXD4 MIXL1 KRT77 CLTA SMARCD2 NR5A1 AJUBA | 4.50e-05 | 1432 | 64 | 18 | M509 |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 7.32e-05 | 96 | 64 | 5 | M39834 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 7.61e-05 | 50 | 64 | 4 | M48087 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 1.03e-04 | 54 | 64 | 4 | M42568 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.41e-04 | 339 | 64 | 8 | M39736 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 3.32e-04 | 30 | 64 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 3.32e-04 | 30 | 64 | 3 | MM15812 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 4.20e-04 | 7 | 64 | 2 | M48265 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 5.58e-04 | 8 | 64 | 2 | M48236 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 8.09e-04 | 161 | 64 | 5 | M39770 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.30e-03 | 12 | 64 | 2 | MM15093 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.30e-03 | 12 | 64 | 2 | M27352 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.30e-03 | 12 | 64 | 2 | MM15452 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 2.27e-03 | 122 | 64 | 4 | M29689 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 2.34e-03 | 16 | 64 | 2 | M9450 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 2.92e-03 | 63 | 64 | 3 | M8 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 2.96e-03 | 18 | 64 | 2 | M39421 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 3.28e-03 | 135 | 64 | 4 | MM14781 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 3.30e-03 | 19 | 64 | 2 | M48230 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 3.78e-03 | 69 | 64 | 3 | M48052 | |
| Pathway | BIOCARTA_P53HYPOXIA_PATHWAY | 4.03e-03 | 21 | 64 | 2 | M5202 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 4.32e-03 | 575 | 64 | 8 | M29853 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 5.69e-03 | 25 | 64 | 2 | M274 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL2A1 COL3A1 COL4A2 COL4A3 COL4A6 COL5A2 COL16A1 COL27A1 COL1A1 COL1A2 | 6.89e-16 | 62 | 89 | 10 | 28344315 |
| Pubmed | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL27A1 COL1A1 COL1A2 | 8.51e-16 | 175 | 89 | 13 | 28071719 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL2A1 COL3A1 COL4A2 COL4A3 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL1A1 COL1A2 | 1.31e-15 | 135 | 89 | 12 | 28675934 |
| Pubmed | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL1A1 COL1A2 | 6.01e-15 | 153 | 89 | 12 | 25037231 | |
| Pubmed | 1.97e-14 | 9 | 89 | 6 | 9878537 | ||
| Pubmed | 2.78e-14 | 19 | 89 | 7 | 15689378 | ||
| Pubmed | COL3A1 COL4A2 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL27A1 COL1A1 COL1A2 | 5.93e-13 | 167 | 89 | 11 | 22159717 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | KLF16 TBX3 HIC1 KMT2D NKX6-2 BHLHE23 RARG ERF HOXD4 MIXL1 TLX3 SKOR1 FOXI2 RELB NR5A1 NKX2-6 HMX1 CIC HSF5 | 1.40e-12 | 908 | 89 | 19 | 19274049 |
| Pubmed | 5.45e-12 | 8 | 89 | 5 | 1377218 | ||
| Pubmed | 5.45e-12 | 8 | 89 | 5 | 3997552 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 5.45e-12 | 8 | 89 | 5 | 11867580 | |
| Pubmed | 5.45e-12 | 8 | 89 | 5 | 10382266 | ||
| Pubmed | 1.22e-11 | 9 | 89 | 5 | 8900172 | ||
| Pubmed | 2.44e-11 | 10 | 89 | 5 | 9415455 | ||
| Pubmed | 5.16e-11 | 50 | 89 | 7 | 23658023 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 6.01e-11 | 86 | 89 | 8 | 28327460 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 7.65e-11 | 12 | 89 | 5 | 12180907 | |
| Pubmed | COL2A1 COL3A1 COL4A2 COL5A2 COL6A1 COL16A1 RNPEP COL1A1 COL1A2 | 1.51e-10 | 146 | 89 | 9 | 27068509 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 9409248 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 11973338 | ||
| Pubmed | 4.18e-10 | 16 | 89 | 5 | 17881772 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 2426947 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 5.99e-10 | 6 | 89 | 4 | 10534397 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 9101290 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 5.99e-10 | 6 | 89 | 4 | 19275937 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 6988303 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 5.99e-10 | 6 | 89 | 4 | 9506531 | |
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 5.99e-10 | 6 | 89 | 4 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 5.99e-10 | 6 | 89 | 4 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 5.99e-10 | 6 | 89 | 4 | 6389236 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 12225806 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 5.99e-10 | 6 | 89 | 4 | 9673377 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 11732842 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | KLF16 TBX3 HIC1 NKX6-2 BHLHE23 RARG HOXD4 MIXL1 TLX3 SKOR1 NR5A1 HMX1 HSF5 | 1.38e-09 | 544 | 89 | 13 | 28473536 |
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 1.39e-09 | 7 | 89 | 4 | 8006028 | |
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 10416788 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 11711546 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 1724753 | ||
| Pubmed | 2.78e-09 | 8 | 89 | 4 | 18816857 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 2.78e-09 | 8 | 89 | 4 | 10970885 | |
| Pubmed | 2.78e-09 | 8 | 89 | 4 | 29422532 | ||
| Pubmed | 2.80e-09 | 87 | 89 | 7 | 20548288 | ||
| Pubmed | 4.01e-09 | 24 | 89 | 5 | 25344368 | ||
| Pubmed | 5.00e-09 | 25 | 89 | 5 | 19180518 | ||
| Pubmed | 5.00e-09 | 9 | 89 | 4 | 12101409 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 6.02e-09 | 97 | 89 | 7 | 27559042 | |
| Pubmed | 8.31e-09 | 10 | 89 | 4 | 2446864 | ||
| Pubmed | 8.31e-09 | 10 | 89 | 4 | 9136074 | ||
| Pubmed | 8.31e-09 | 10 | 89 | 4 | 14559231 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 1.30e-08 | 11 | 89 | 4 | 7500359 | |
| Pubmed | 1.30e-08 | 11 | 89 | 4 | 14998921 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 23546968 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 17662583 | ||
| Pubmed | Distributions of types I, II and III collagen by region in the human supraspinatus tendon. | 1.62e-08 | 3 | 89 | 3 | 24088220 | |
| Pubmed | Mutations in collagen genes: causes of rare and some common diseases in humans. | 1.62e-08 | 3 | 89 | 3 | 2010058 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 34205850 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 3089234 | ||
| Pubmed | Coordinate patterns of expression of type I and III collagens during mouse development. | 1.62e-08 | 3 | 89 | 3 | 8785585 | |
| Pubmed | Differential expression of type I and type III collagen genes during tooth development. | 1.62e-08 | 3 | 89 | 3 | 1879336 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 12200454 | ||
| Pubmed | Localization of pro-alpha 2(V) collagen transcripts in the tissues of the developing mouse embryo. | 1.62e-08 | 3 | 89 | 3 | 1297453 | |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 1.95e-08 | 12 | 89 | 4 | 15837576 | |
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 16024816 | ||
| Pubmed | 2.65e-08 | 263 | 89 | 9 | 20932939 | ||
| Pubmed | 2.81e-08 | 186 | 89 | 8 | 20673868 | ||
| Pubmed | 2.81e-08 | 186 | 89 | 8 | 20452482 | ||
| Pubmed | The Mohawk homeobox gene is a critical regulator of tendon differentiation. | 2.81e-08 | 13 | 89 | 4 | 20498044 | |
| Pubmed | 3.93e-08 | 14 | 89 | 4 | 12878203 | ||
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 5.35e-08 | 15 | 89 | 4 | 9832566 | |
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 6.47e-08 | 4 | 89 | 3 | 7827955 | |
| Pubmed | Localization of types I and III collagen and fibronectin in the developing mouse palatal shelves. | 6.47e-08 | 4 | 89 | 3 | 8984825 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 10633870 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 24361166 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 32945508 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 1409674 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 16537906 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 12874293 | ||
| Pubmed | Immunohistochemical characteristics of developing mandibular angle in fetal mice. | 6.47e-08 | 4 | 89 | 3 | 16356873 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 9880238 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 19932771 | ||
| Pubmed | Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. | 6.47e-08 | 4 | 89 | 3 | 2054384 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 8686743 | ||
| Pubmed | 7.12e-08 | 16 | 89 | 4 | 15878328 | ||
| Pubmed | 7.18e-08 | 210 | 89 | 8 | 16537572 | ||
| Pubmed | The Type 3 Deiodinase Is a Critical Modulator of Thyroid Hormone Sensitivity in the Fetal Brain. | 1.10e-07 | 45 | 89 | 5 | 34248495 | |
| Pubmed | An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. | 1.61e-07 | 5 | 89 | 3 | 9659900 | |
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 19790048 | ||
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 1.61e-07 | 5 | 89 | 3 | 14758483 | |
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 15365990 | ||
| Pubmed | Extracellular matrix protein expression during mouse detrusor development. | 1.61e-07 | 5 | 89 | 3 | 12592609 | |
| Pubmed | 2.32e-07 | 21 | 89 | 4 | 27856617 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 3.22e-07 | 6 | 89 | 3 | 17029294 | |
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 15514164 | ||
| Pubmed | Development and regeneration of the neonatal digit tip in mice. | 3.22e-07 | 6 | 89 | 3 | 18234177 | |
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 16192629 | ||
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 21467034 | ||
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 7813775 | ||
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 7495302 | ||
| Pubmed | 3.22e-07 | 6 | 89 | 3 | 17135260 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 3.22e-07 | 6 | 89 | 3 | 8563024 | |
| Interaction | MMP9 interactions | COL2A1 COL4A2 COL4A3 COL4A4 COL4A6 COL6A1 MMP27 COL1A1 COL1A2 | 1.46e-11 | 67 | 89 | 9 | int:MMP9 |
| Interaction | LAIR2 interactions | 4.08e-11 | 49 | 89 | 8 | int:LAIR2 | |
| Interaction | TGFBI interactions | 1.03e-09 | 25 | 89 | 6 | int:TGFBI | |
| Interaction | MMP2 interactions | 4.62e-09 | 87 | 89 | 8 | int:MMP2 | |
| Interaction | DCN interactions | 3.34e-08 | 43 | 89 | 6 | int:DCN | |
| Interaction | CD93 interactions | 4.43e-08 | 45 | 89 | 6 | int:CD93 | |
| Interaction | C1QTNF1 interactions | 5.81e-08 | 47 | 89 | 6 | int:C1QTNF1 | |
| Interaction | BGN interactions | 1.96e-07 | 30 | 89 | 5 | int:BGN | |
| Interaction | PDGFA interactions | 2.75e-07 | 32 | 89 | 5 | int:PDGFA | |
| Interaction | COLGALT2 interactions | 5.03e-07 | 67 | 89 | 6 | int:COLGALT2 | |
| Interaction | FGF7 interactions | 6.21e-07 | 16 | 89 | 4 | int:FGF7 | |
| Interaction | HABP2 interactions | 1.04e-06 | 18 | 89 | 4 | int:HABP2 | |
| Interaction | OSM interactions | 1.63e-06 | 20 | 89 | 4 | int:OSM | |
| Interaction | TLE3 interactions | 6.23e-06 | 376 | 89 | 10 | int:TLE3 | |
| Interaction | NFIX interactions | 7.39e-06 | 227 | 89 | 8 | int:NFIX | |
| Interaction | MAG interactions | 7.76e-06 | 29 | 89 | 4 | int:MAG | |
| Interaction | COL9A1 interactions | 2.31e-05 | 13 | 89 | 3 | int:COL9A1 | |
| Interaction | COL1A2 interactions | 2.46e-05 | 78 | 89 | 5 | int:COL1A2 | |
| Interaction | SMAD3 interactions | 2.77e-05 | 447 | 89 | 10 | int:SMAD3 | |
| Interaction | COL8A2 interactions | 3.50e-05 | 42 | 89 | 4 | int:COL8A2 | |
| Interaction | TCF7L2 interactions | 3.80e-05 | 285 | 89 | 8 | int:TCF7L2 | |
| Interaction | PDGFB interactions | 4.40e-05 | 88 | 89 | 5 | int:PDGFB | |
| Interaction | PLOD1 interactions | 4.51e-05 | 292 | 89 | 8 | int:PLOD1 | |
| Interaction | PAX3 interactions | 8.18e-05 | 52 | 89 | 4 | int:PAX3 | |
| Interaction | SERPINE2 interactions | 1.10e-04 | 56 | 89 | 4 | int:SERPINE2 | |
| Interaction | MATN2 interactions | 1.45e-04 | 113 | 89 | 5 | int:MATN2 | |
| Interaction | LSM14A interactions | 1.54e-04 | 260 | 89 | 7 | int:LSM14A | |
| Interaction | PLOD3 interactions | 1.61e-04 | 183 | 89 | 6 | int:PLOD3 | |
| Interaction | RMI2 interactions | 1.78e-04 | 25 | 89 | 3 | int:RMI2 | |
| Interaction | DEAF1 interactions | 1.84e-04 | 64 | 89 | 4 | int:DEAF1 | |
| Interaction | SPARC interactions | 1.96e-04 | 65 | 89 | 4 | int:SPARC | |
| Interaction | FBLN2 interactions | 2.08e-04 | 66 | 89 | 4 | int:FBLN2 | |
| Interaction | TIMP2 interactions | 2.26e-04 | 277 | 89 | 7 | int:TIMP2 | |
| Interaction | ETV4 interactions | 2.47e-04 | 69 | 89 | 4 | int:ETV4 | |
| Interaction | SMAD7 interactions | 2.50e-04 | 127 | 89 | 5 | int:SMAD7 | |
| Interaction | PITX1 interactions | 2.50e-04 | 127 | 89 | 5 | int:PITX1 | |
| Interaction | MARF1 interactions | 2.59e-04 | 128 | 89 | 5 | int:MARF1 | |
| Interaction | COL5A2 interactions | 2.80e-04 | 29 | 89 | 3 | int:COL5A2 | |
| Interaction | ANTXR2 interactions | 2.80e-04 | 29 | 89 | 3 | int:ANTXR2 | |
| Interaction | NFIC interactions | 3.37e-04 | 210 | 89 | 6 | int:NFIC | |
| Interaction | COL4A2 interactions | 3.40e-04 | 75 | 89 | 4 | int:COL4A2 | |
| Interaction | VWF interactions | 3.76e-04 | 32 | 89 | 3 | int:VWF | |
| Interaction | NFIB interactions | 4.18e-04 | 142 | 89 | 5 | int:NFIB | |
| Interaction | HNF1A interactions | 4.35e-04 | 80 | 89 | 4 | int:HNF1A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.07e-04 | 1192 | 89 | 10 | chr19q13 | |
| Cytoband | 19q13.1 | 1.72e-04 | 55 | 89 | 3 | 19q13.1 | |
| Cytoband | 9p13 | 9.16e-04 | 23 | 89 | 2 | 9p13 | |
| Cytoband | 8p21.2 | 1.08e-03 | 25 | 89 | 2 | 8p21.2 | |
| Cytoband | 19p13.3 | 1.20e-03 | 237 | 89 | 4 | 19p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 1.43e-03 | 423 | 89 | 5 | chr12q13 | |
| GeneFamily | Collagens | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 2.32e-24 | 46 | 64 | 14 | 490 |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 9.26e-05 | 67 | 64 | 4 | 519 | |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 9.81e-25 | 44 | 89 | 14 | M3005 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL27A1 COL1A1 COL1A2 | 1.07e-22 | 43 | 89 | 13 | MM17060 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 TSKU COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 2.67e-14 | 275 | 89 | 15 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 TSKU COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL27A1 COL1A1 COL1A2 | 4.14e-13 | 270 | 89 | 14 | MM17057 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 5.76e-10 | 29 | 89 | 6 | MM17055 | |
| Coexpression | NABA_MATRISOME | COL2A1 COL3A1 TSKU COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 CBLN3 COL16A1 COL21A1 COL27A1 MMP27 COL1A1 COL1A2 | 5.55e-08 | 1026 | 89 | 17 | M5889 |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.21e-07 | 35 | 89 | 5 | MM17054 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.55e-07 | 71 | 89 | 6 | M3955 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | COL2A1 COL4A6 COL24A1 TBX3 HIC1 NKX6-2 BHLHE23 HOXD4 COL27A1 DUSP8 TLX3 KCNQ1 ECEL1 NXPH4 CNTFR NOVA2 HR | 1.82e-07 | 1115 | 89 | 17 | M10371 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.41e-07 | 40 | 89 | 5 | M5887 | |
| Coexpression | NABA_MATRISOME | COL2A1 COL3A1 TSKU COL4A2 COL4A3 COL4A4 COL4A6 COL5A2 COL6A1 COL24A1 CBLN3 COL16A1 COL27A1 MMP27 COL1A1 COL1A2 | 2.57e-07 | 1008 | 89 | 16 | MM17056 |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 3.42e-07 | 81 | 89 | 6 | M39253 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | COL3A1 COL4A2 COL5A2 HIC1 RARG COL21A1 COL27A1 NOTCH3 COL1A1 COL1A2 | 7.55e-07 | 385 | 89 | 10 | M39264 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.05e-06 | 23 | 89 | 4 | M48001 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL3A1 TSKU COL4A2 COL5A2 COL6A1 COL16A1 HOXD4 COL21A1 TMEM64 NOTCH3 CNTFR COL1A1 COL1A2 | 1.89e-06 | 767 | 89 | 13 | M39209 |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 2.24e-06 | 62 | 89 | 5 | M16774 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | SLC8A2 NKX6-2 BHLHE23 HOXD4 MIXL1 ADGRB1 SKOR1 KCNQ1 ECEL1 HMX1 | 2.40e-06 | 438 | 89 | 10 | M1954 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | SLC8A2 NKX6-2 BHLHE23 HOXD4 MIXL1 ADGRB1 SKOR1 KCNQ1 ECEL1 HMX1 | 2.50e-06 | 440 | 89 | 10 | MM832 |
| Coexpression | BENPORATH_EED_TARGETS | COL2A1 MAGI2 COL4A6 COL24A1 TBX3 HIC1 NKX6-2 BHLHE23 HOXD4 COL27A1 TLX3 KCNQ1 ECEL1 NXPH4 CNTFR | 2.62e-06 | 1059 | 89 | 15 | M7617 |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | 2.69e-06 | 345 | 89 | 9 | M2009 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | 2.82e-06 | 347 | 89 | 9 | MM860 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 2.83e-06 | 65 | 89 | 5 | M39309 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 2.99e-06 | 117 | 89 | 6 | M39300 | |
| Coexpression | BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN | 3.14e-06 | 118 | 89 | 6 | M34005 | |
| Coexpression | URS_ADIPOCYTE_DIFFERENTIATION_DN | 3.64e-06 | 31 | 89 | 4 | M18395 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 4.59e-06 | 126 | 89 | 6 | M39132 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 5.40e-06 | 74 | 89 | 5 | M13547 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 5.88e-06 | 202 | 89 | 7 | M38982 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 6.00e-06 | 35 | 89 | 4 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 6.73e-06 | 36 | 89 | 4 | MM1212 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 7.44e-06 | 137 | 89 | 6 | M40313 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL3A1 COL4A2 COL4A6 COL5A2 COL6A1 COL27A1 SHANK3 NOTCH3 COL1A1 COL1A2 | 8.41e-06 | 505 | 89 | 10 | M39167 |
| Coexpression | PEREZ_TP53_TARGETS | COL2A1 COL4A4 COL5A2 COL6A1 HIC1 PAXBP1 CEBPA FOXO6 COL21A1 COL27A1 KCNQ1 PRR22 NANOS1 TMEM64 HR | 1.19e-05 | 1201 | 89 | 15 | M4391 |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 1.41e-05 | 90 | 89 | 5 | M38984 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 1.49e-05 | 91 | 89 | 5 | M40180 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 1.52e-05 | 44 | 89 | 4 | M18274 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 1.93e-05 | 162 | 89 | 6 | M45037 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | COL3A1 COL4A2 COL5A2 COL6A1 SSC5D TBX3 HIC1 COL16A1 NOTCH3 COL1A1 COL1A2 | 1.95e-05 | 681 | 89 | 11 | M39175 |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.98e-05 | 47 | 89 | 4 | M7585 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_STROMAL_CELLS | 2.24e-05 | 99 | 89 | 5 | M40255 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 2.24e-05 | 99 | 89 | 5 | M39152 | |
| Coexpression | DANG_REGULATED_BY_MYC_DN | 2.40e-05 | 251 | 89 | 7 | M2310 | |
| Coexpression | KANG_AR_TARGETS_UP | 2.49e-05 | 17 | 89 | 3 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 2.49e-05 | 17 | 89 | 3 | M2223 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.98e-05 | 18 | 89 | 3 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.98e-05 | 18 | 89 | 3 | M13796 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | SLC8A2 NKX6-2 BHLHE23 HOXD4 TLX3 ADGRB1 SKOR1 KCNQ1 ECEL1 HMX1 | 3.24e-05 | 591 | 89 | 10 | M2019 |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 3.53e-05 | 19 | 89 | 3 | M15125 | |
| Coexpression | SENESE_HDAC1_TARGETS_DN | 3.56e-05 | 267 | 89 | 7 | M6100 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | SLC8A2 NKX6-2 BHLHE23 HOXD4 TLX3 ADGRB1 SKOR1 KCNQ1 ECEL1 HMX1 | 3.73e-05 | 601 | 89 | 10 | MM866 |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS | 4.24e-05 | 113 | 89 | 5 | M43610 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 4.58e-05 | 58 | 89 | 4 | M178 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C2 | 4.82e-05 | 21 | 89 | 3 | M4767 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 6.29e-05 | 200 | 89 | 6 | M5930 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP | 6.29e-05 | 200 | 89 | 6 | M7333 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 6.75e-05 | 64 | 89 | 4 | M2572 | |
| Coexpression | BENPORATH_PRC2_TARGETS | COL2A1 COL4A6 COL24A1 TBX3 NKX6-2 BHLHE23 HOXD4 COL27A1 ECEL1 CNTFR | 7.18e-05 | 650 | 89 | 10 | M8448 |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 8.57e-05 | 68 | 89 | 4 | M1373 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 9.07e-05 | 69 | 89 | 4 | M10165 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.07e-04 | 72 | 89 | 4 | MM1131 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 1.19e-04 | 74 | 89 | 4 | M4479 | |
| Coexpression | NAKAMURA_CANCER_MICROENVIRONMENT_UP | 1.30e-04 | 29 | 89 | 3 | M7581 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 1.34e-04 | 144 | 89 | 5 | M5942 | |
| Coexpression | HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS | 1.39e-04 | 77 | 89 | 4 | M19128 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 1.52e-04 | 235 | 89 | 6 | M5311 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.54e-04 | 79 | 89 | 4 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.61e-04 | 80 | 89 | 4 | MM1285 | |
| Coexpression | SENESE_HDAC1_AND_HDAC2_TARGETS_DN | 1.63e-04 | 238 | 89 | 6 | M12004 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 1.69e-04 | 6 | 89 | 2 | M48000 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 1.92e-04 | 350 | 89 | 7 | M1949 | |
| Coexpression | ZHU_CMV_24_HR_DN | 1.95e-04 | 84 | 89 | 4 | M4065 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 1.99e-04 | 352 | 89 | 7 | M17471 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 2.10e-04 | 34 | 89 | 3 | M1955 | |
| Coexpression | PEREZ_TP63_TARGETS | 2.13e-04 | 356 | 89 | 7 | M10761 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 2.17e-04 | 357 | 89 | 7 | MM828 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 2.38e-04 | 163 | 89 | 5 | M2769 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 2.49e-04 | 36 | 89 | 3 | MM833 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.68e-04 | 261 | 89 | 6 | M1834 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 2.76e-04 | 493 | 89 | 8 | M19391 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN | 2.88e-04 | 93 | 89 | 4 | M4752 | |
| Coexpression | KOYAMA_SEMA3B_TARGETS_UP | 3.09e-04 | 268 | 89 | 6 | M12746 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 3.15e-04 | 503 | 89 | 8 | M2226 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 3.34e-04 | 272 | 89 | 6 | M1938 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 3.41e-04 | 40 | 89 | 3 | M1574 | |
| Coexpression | QI_PLASMACYTOMA_DN | 3.52e-04 | 98 | 89 | 4 | M1852 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | COL3A1 COL4A2 COL5A2 COL6A1 HIC1 RARG ERF COL21A1 NOTCH3 COL1A2 | 3.65e-04 | 795 | 89 | 10 | M39050 |
| Coexpression | HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN | 3.67e-04 | 41 | 89 | 3 | M41210 | |
| Coexpression | QI_PLASMACYTOMA_DN | 3.80e-04 | 100 | 89 | 4 | MM775 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 4.05e-04 | 282 | 89 | 6 | MM822 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K27ME3 | 4.23e-04 | 43 | 89 | 3 | MM854 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K27ME3 | 4.23e-04 | 43 | 89 | 3 | M2003 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 5.05e-04 | 192 | 89 | 5 | M42501 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 5.11e-04 | 541 | 89 | 8 | MM1061 | |
| Coexpression | JONES_OVARY_THECA | 5.17e-04 | 46 | 89 | 3 | M48349 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 5.17e-04 | 46 | 89 | 3 | MM670 | |
| Coexpression | MARCHINI_TRABECTEDIN_RESISTANCE_DN | 5.17e-04 | 46 | 89 | 3 | M8349 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 5.17e-04 | 46 | 89 | 3 | MM544 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 5.23e-04 | 296 | 89 | 6 | M41675 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 5.29e-04 | 194 | 89 | 5 | M39122 | |
| Coexpression | GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN | 5.42e-04 | 195 | 89 | 5 | M9309 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 2.77e-07 | 66 | 86 | 6 | BM Top 100 - endometrium | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL2A1 COL3A1 COL4A2 COL5A2 SSC5D TBX3 HIC1 CBLN3 NKX6-2 HOXD4 TLX3 ANKRD34A HMX1 CNTFR COL1A1 COL1A2 | 7.08e-06 | 1094 | 86 | 16 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | BM Top 100 - cervix | 7.13e-06 | 66 | 86 | 5 | BM Top 100 - cervix | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 2.33e-05 | 84 | 86 | 5 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | COL3A1 COL6A1 SEC16B SSC5D TBX3 HIC1 CBLN3 COL16A1 RARG ANKRD34A NKX2-6 COL1A1 HR COL1A2 | 3.74e-05 | 981 | 86 | 14 | PCBC_ctl_BronchSmoothMuscl_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 4.22e-05 | 95 | 86 | 5 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | 1.14e-04 | 117 | 86 | 5 | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.45e-04 | 281 | 86 | 7 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.45e-04 | 281 | 86 | 7 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.49e-04 | 66 | 86 | 4 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 1.77e-04 | 69 | 86 | 4 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 1.88e-04 | 70 | 86 | 4 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 1.91e-04 | 206 | 86 | 6 | JC_fibro_500_K3 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 2.09e-04 | 72 | 86 | 4 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 2.21e-04 | 73 | 86 | 4 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | BM Top 100 - mammary gland | 2.32e-04 | 74 | 86 | 4 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 2.32e-04 | 74 | 86 | 4 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 3.21e-04 | 320 | 86 | 7 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.79e-04 | 234 | 86 | 6 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 3.96e-04 | 85 | 86 | 4 | GSM777067_100 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | 4.51e-04 | 88 | 86 | 4 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 5.15e-04 | 455 | 86 | 8 | GSM777055_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 5.26e-04 | 249 | 86 | 6 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 6.02e-04 | 466 | 86 | 8 | GSM777050_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | COL2A1 COL3A1 COL5A2 SSC5D TBX3 HIC1 HOXD4 TLX3 CNTFR COL1A1 HR COL1A2 | 6.49e-04 | 994 | 86 | 12 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 6.52e-04 | 97 | 86 | 4 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 6.52e-04 | 97 | 86 | 4 | GSM777046_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.73e-04 | 371 | 86 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | COL3A1 COL4A2 COL5A2 COL6A1 COL24A1 SSC5D TBX3 COL16A1 COL27A1 COL1A1 COL1A2 | 1.47e-13 | 189 | 89 | 11 | 44e37f88137bb249933eb615235b2cf2ae7f3925 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL3A1 COL5A2 COL6A1 SSC5D COL16A1 COL27A1 CNTFR COL1A1 COL1A2 | 5.14e-12 | 189 | 89 | 10 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL3A1 COL5A2 COL6A1 SSC5D COL16A1 COL27A1 CNTFR COL1A1 COL1A2 | 5.14e-12 | 189 | 89 | 10 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A6 COL5A2 COL6A1 SSC5D COL16A1 NR5A1 CNTFR COL1A1 COL1A2 | 5.41e-12 | 190 | 89 | 10 | c7bd087f36321cec61b98657433b4d19d135791f |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A6 COL5A2 COL6A1 SSC5D COL16A1 NR5A1 CNTFR COL1A1 COL1A2 | 5.41e-12 | 190 | 89 | 10 | 834218fcc59df5e7e52de154272f3d55d81d0dac |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL3A1 COL5A2 COL6A1 SSC5D COL16A1 COL27A1 CNTFR COL1A1 COL1A2 | 5.70e-12 | 191 | 89 | 10 | 5271198116343c07202649889057e5774d7fdde3 |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A3 COL4A4 COL5A2 COL6A1 SSC5D COL16A1 TMEM64 COL1A1 COL1A2 | 6.01e-12 | 192 | 89 | 10 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A3 COL4A4 COL5A2 COL6A1 SSC5D COL16A1 TMEM64 COL1A1 COL1A2 | 6.01e-12 | 192 | 89 | 10 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | COL3A1 COL5A2 COL6A1 COL24A1 TBX3 COL16A1 COL21A1 CNTFR COL1A1 COL1A2 | 7.37e-12 | 196 | 89 | 10 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | COL3A1 COL4A4 COL5A2 COL6A1 SSC5D COL16A1 COL27A1 ADCY5 COL1A1 COL1A2 | 8.15e-12 | 198 | 89 | 10 | bd11b0e9e80449aab979a02c1023e0638c431c7c |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.66e-11 | 174 | 89 | 9 | 2627c3983009839fedbc5e3f628739dc026447f4 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.66e-11 | 174 | 89 | 9 | 507a33e58f62e2b72f0bcc743e84dbd0bf705a15 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-11 | 175 | 89 | 9 | b4f01e7782cdd107d0817ef601891fd3a382bc35 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-11 | 175 | 89 | 9 | ef6f811d8e1839f405c3b41090ddf79be57a099f | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-11 | 175 | 89 | 9 | 7f7598d46d10bff1cbea42f950bdde1aaa16e9a4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-10 | 181 | 89 | 9 | 634a4f4e5942473e60d08d0b0936407b04bc6b7c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-10 | 181 | 89 | 9 | c2938cf1f5d4875be07a56a1f36c94f8eab37d99 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-10 | 183 | 89 | 9 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | COL3A1 COL5A2 COL6A1 COL24A1 SSC5D COL16A1 COL27A1 COL1A1 COL1A2 | 1.26e-10 | 184 | 89 | 9 | 0b336489c10e8c3c957795dd845454f03404382b |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL3A1 COL4A3 COL4A4 COL5A2 COL6A1 COL24A1 SSC5D COL1A1 COL1A2 | 1.46e-10 | 187 | 89 | 9 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL3A1 COL4A2 COL4A6 COL5A2 COL6A1 COL24A1 COL16A1 COL1A1 COL1A2 | 1.53e-10 | 188 | 89 | 9 | b382d18fb09fb2869f3c151efa71540a7f5ed229 |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | COL2A1 COL3A1 COL6A1 COL24A1 COL16A1 RARG COL27A1 COL1A1 COL1A2 | 1.53e-10 | 188 | 89 | 9 | 7b1e3f8a941eaa68e89c562129a92314642eec66 |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.68e-10 | 190 | 89 | 9 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A4 COL5A2 COL6A1 SSC5D COL16A1 NOTCH3 COL1A1 COL1A2 | 1.76e-10 | 191 | 89 | 9 | b7a57691a4742070cee640e285c1f4d0da95baf1 |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.76e-10 | 191 | 89 | 9 | fd8331c7abdd999f55ba43d307945c6abfccbf84 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-10 | 192 | 89 | 9 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL3A1 COL5A2 COL6A1 COL24A1 SSC5D TBX3 COL16A1 COL1A1 COL1A2 | 2.02e-10 | 194 | 89 | 9 | 8fae8061b350336299aa81f378e07deadbd55123 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL3A1 COL5A2 COL6A1 COL24A1 SSC5D TBX3 COL16A1 COL1A1 COL1A2 | 2.02e-10 | 194 | 89 | 9 | 4d7d24390fdb379f943ddcc70a63f23955e10163 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A2 COL5A2 COL6A1 SEC16B ANKRD34A NOTCH3 COL1A1 COL1A2 | 2.11e-10 | 195 | 89 | 9 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-10 | 196 | 89 | 9 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A2 COL5A2 COL6A1 COL16A1 COL27A1 CNTFR COL1A1 COL1A2 | 2.31e-10 | 197 | 89 | 9 | 86145bc1e585b4ae136e755cafd6579da2abfa65 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL3A1 COL5A2 COL6A1 COL24A1 SSC5D TBX3 COL16A1 COL1A1 COL1A2 | 2.31e-10 | 197 | 89 | 9 | 16758f181ef07c60aee63072e1da9572c5c85414 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL5A2 SSC5D HIC1 COL16A1 COL21A1 CNTFR COL1A1 COL1A2 | 2.31e-10 | 197 | 89 | 9 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL3A1 COL4A2 COL6A1 COL27A1 ECEL1 ADCY5 NOTCH3 COL1A1 COL1A2 | 2.42e-10 | 198 | 89 | 9 | dc6d9032c5029527e184ac13b887c0c1f22ef1c0 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL3A1 COL4A2 COL5A2 COL6A1 SSC5D COL16A1 COL1A1 COL1A2 | 2.42e-10 | 198 | 89 | 9 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL3A1 COL5A2 COL6A1 SSC5D COL16A1 CNTFR COL1A1 COL1A2 | 2.42e-10 | 198 | 89 | 9 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | COL3A1 COL4A2 MAGI2 COL5A2 COL6A1 COL16A1 COL21A1 COL1A1 COL1A2 | 2.42e-10 | 198 | 89 | 9 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL4A2 COL5A2 COL6A1 COL16A1 COL21A1 CNTFR COL1A1 COL1A2 | 2.53e-10 | 199 | 89 | 9 | 84545ced0c792bc77980a50d65e484eab648d47e |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL4A2 COL4A6 COL5A2 COL6A1 TBX3 COL27A1 COL1A1 COL1A2 | 2.53e-10 | 199 | 89 | 9 | ec74ff85d6b61013b1f785b2fca343759feb7843 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | COL3A1 COL4A2 MAGI2 COL5A2 COL6A1 COL16A1 COL21A1 COL1A1 COL1A2 | 2.53e-10 | 199 | 89 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | COL3A1 COL5A2 COL6A1 COL16A1 COL21A1 NXPH4 CNTFR COL1A1 COL1A2 | 2.53e-10 | 199 | 89 | 9 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-10 | 199 | 89 | 9 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | COL3A1 COL5A2 COL6A1 SSC5D COL16A1 COL21A1 CNTFR COL1A1 COL1A2 | 2.53e-10 | 199 | 89 | 9 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-10 | 199 | 89 | 9 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | COL3A1 COL5A2 COL6A1 COL16A1 COL21A1 PLPPR3 CNTFR COL1A1 COL1A2 | 2.53e-10 | 199 | 89 | 9 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL3A1 COL4A2 COL6A1 COL27A1 ECEL1 ADCY5 NOTCH3 COL1A1 COL1A2 | 2.53e-10 | 199 | 89 | 9 | ad75e5e26c37a97331164d7f77235ebd9a933a44 |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL5A2 COL6A1 COL24A1 COL16A1 COL21A1 CNTFR COL1A1 COL1A2 | 2.53e-10 | 199 | 89 | 9 | 08bdcabc3fce787578a8eb66fc8412b0974fa6cc |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.53e-10 | 199 | 89 | 9 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | COL3A1 COL5A2 COL6A1 COL24A1 SSC5D COL16A1 COL27A1 COL1A1 COL1A2 | 2.65e-10 | 200 | 89 | 9 | 069c8949b33ecfdb6da32992002d4060ff6082bc |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | COL3A1 COL5A2 COL6A1 COL16A1 COL21A1 PLPPR3 CNTFR COL1A1 COL1A2 | 2.65e-10 | 200 | 89 | 9 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL3A1 COL4A2 COL5A2 COL6A1 TBX3 COL21A1 CNTFR COL1A1 COL1A2 | 2.65e-10 | 200 | 89 | 9 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 2.65e-10 | 200 | 89 | 9 | 14ae55660f7412518dcb5cb982f6fe9f23553cfb | |
| ToppCell | proximal-mesenchymal-Fibromyocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.65e-10 | 200 | 89 | 9 | 37d9f46f727a31e8e94e348e4ddd71a2125ba01a | |
| ToppCell | proximal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.65e-10 | 200 | 89 | 9 | ed6fbe61a04d29b105054f7058abe7469314b304 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.65e-10 | 200 | 89 | 9 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | distal-mesenchymal-Myofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | COL3A1 COL5A2 COL6A1 COL24A1 SSC5D COL16A1 CNTFR COL1A1 COL1A2 | 2.65e-10 | 200 | 89 | 9 | 61854a459385cd9295be37157a8f81a2c227dff3 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.65e-10 | 200 | 89 | 9 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL3A1 COL4A2 COL5A2 COL6A1 SSC5D ADCY5 NOTCH3 COL1A1 COL1A2 | 2.65e-10 | 200 | 89 | 9 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL3A1 COL4A2 COL5A2 COL6A1 COL27A1 ECEL1 NOTCH3 COL1A1 COL1A2 | 2.65e-10 | 200 | 89 | 9 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | COL3A1 COL5A2 COL6A1 COL24A1 SSC5D TBX3 COL16A1 COL1A1 COL1A2 | 2.65e-10 | 200 | 89 | 9 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | COL3A1 COL5A2 COL6A1 COL16A1 COL21A1 PLPPR3 CNTFR COL1A1 COL1A2 | 2.65e-10 | 200 | 89 | 9 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e |
| ToppCell | proximal-mesenchymal-Fibromyocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.65e-10 | 200 | 89 | 9 | 49658e1b530de0dad16d45a1112bdf5329bb800d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-09 | 164 | 89 | 8 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-09 | 165 | 89 | 8 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.75e-09 | 168 | 89 | 8 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.20e-09 | 173 | 89 | 8 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | Control-Stromal-Pericyte|Control / Disease state, Lineage and Cell class | 2.30e-09 | 174 | 89 | 8 | 91fc1f1c891f105a91968c22e2de5321c52b439a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-09 | 176 | 89 | 8 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-09 | 176 | 89 | 8 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-09 | 177 | 89 | 8 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-09 | 177 | 89 | 8 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.75e-09 | 178 | 89 | 8 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-09 | 180 | 89 | 8 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-09 | 180 | 89 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-09 | 180 | 89 | 8 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.01e-09 | 180 | 89 | 8 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-09 | 180 | 89 | 8 | 1ade66352570a3f869e21e1055d0a65fbf56c61d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-09 | 180 | 89 | 8 | f118c580134bdf3027e2218690cfc8a93468c1ae | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-09 | 180 | 89 | 8 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 3.01e-09 | 180 | 89 | 8 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.43e-09 | 183 | 89 | 8 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.43e-09 | 183 | 89 | 8 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.43e-09 | 183 | 89 | 8 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.73e-09 | 185 | 89 | 8 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.73e-09 | 185 | 89 | 8 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 3.89e-09 | 186 | 89 | 8 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-09 | 186 | 89 | 8 | 07d94d5d1c2fe7bb909a07ca81058a0eabc65c60 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.06e-09 | 187 | 89 | 8 | 150023e6a50c9da461f2321074d2d5e96caafb06 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.06e-09 | 187 | 89 | 8 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.23e-09 | 188 | 89 | 8 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-09 | 189 | 89 | 8 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.41e-09 | 189 | 89 | 8 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-09 | 191 | 89 | 8 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.79e-09 | 191 | 89 | 8 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-09 | 192 | 89 | 8 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-09 | 192 | 89 | 8 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-09 | 192 | 89 | 8 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-09 | 192 | 89 | 8 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 4.99e-09 | 192 | 89 | 8 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-09 | 192 | 89 | 8 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| Computational | Neighborhood of CDH11 | 7.92e-08 | 25 | 49 | 5 | GNF2_CDH11 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.90e-06 | 50 | 49 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | ECM and collagens. | 7.01e-06 | 225 | 49 | 8 | MODULE_47 | |
| Computational | Neighborhood of PTX3 | 2.02e-05 | 36 | 49 | 4 | GNF2_PTX3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.52e-05 | 50 | 49 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Fetal liver genes - metabolism and xenobiotics. | COL2A1 COL3A1 COL5A2 COL6A1 TM7SF2 KCNQ1 NXPH4 COL1A1 COL1A2 | 1.77e-04 | 453 | 49 | 9 | MODULE_24 |
| Computational | Placenta genes. | COL2A1 COL3A1 COL5A2 COL6A1 FCGBP SMARCD2 NOTCH3 COL1A1 COL1A2 | 2.08e-04 | 463 | 49 | 9 | MODULE_38 |
| Computational | Adhesion molecules. | 4.34e-04 | 141 | 49 | 5 | MODULE_122 | |
| Computational | Spinal cord (neuro-development) genes. | 1.14e-03 | 360 | 49 | 7 | MODULE_12 | |
| Computational | Ovary genes. | 1.29e-03 | 368 | 49 | 7 | MODULE_1 | |
| Drug | GK-101 | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 9.52e-19 | 36 | 89 | 11 | CID000161853 |
| Drug | halofuginone lactate | COL2A1 COL3A1 TSKU COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 RELB COL1A1 COL1A2 | 1.17e-17 | 85 | 89 | 13 | CID000062891 |
| Drug | Madecassol | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 2.05e-17 | 46 | 89 | 11 | CID000108062 |
| Drug | d-indobufen | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 5.66e-17 | 50 | 89 | 11 | CID000044562 |
| Drug | ridogrel | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 9.10e-17 | 52 | 89 | 11 | CID005362391 |
| Drug | NSC49633 | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.15e-16 | 53 | 89 | 11 | CID000023340 |
| Drug | AC1L1C2F | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 BHLHE23 COL16A1 COL21A1 COL27A1 KCNQ1 COL1A1 COL1A2 | 3.90e-16 | 110 | 89 | 13 | CID000001711 |
| Drug | AC1LAKND | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.42e-16 | 62 | 89 | 11 | CID000470146 |
| Drug | Selara | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 RELB NANOS1 COL1A1 COL1A2 | 2.15e-15 | 125 | 89 | 13 | CID000150310 |
| Drug | malotilate | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 3.63e-15 | 71 | 89 | 11 | CID000004006 |
| Drug | BAPN | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 3.63e-15 | 71 | 89 | 11 | CID000001647 |
| Drug | ticlopidine | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 ECEL1 COL1A1 COL1A2 | 6.76e-15 | 103 | 89 | 12 | CID000005472 |
| Drug | AC1NMZ1B | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 6.87e-15 | 75 | 89 | 11 | CID005034185 |
| Drug | strontium ranelate | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 9.31e-15 | 77 | 89 | 11 | CID006918182 |
| Drug | PPACK | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 RELB COL1A1 COL1A2 | 2.12e-14 | 113 | 89 | 12 | CID003036757 |
| Drug | 4-hydroxyproline | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 6.31e-14 | 91 | 89 | 11 | CID000000825 |
| Drug | pirfenidone | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 MMP27 COL1A1 COL1A2 | 2.41e-13 | 138 | 89 | 12 | CID000040632 |
| Drug | DL-penicillamine | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 NANOS1 COL1A1 COL1A2 | 2.63e-13 | 139 | 89 | 12 | CID000004727 |
| Drug | PCR 4099 | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 ADCY5 COL1A1 COL1A2 | 2.63e-13 | 139 | 89 | 12 | CID000002806 |
| Drug | hydroxylysine | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 4.83e-13 | 109 | 89 | 11 | CID000001029 |
| Drug | AC1L9732 | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 7.98e-13 | 114 | 89 | 11 | CID000439300 |
| Drug | Tranilast sodium | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 8.79e-13 | 115 | 89 | 11 | CID000005527 |
| Drug | DMSe | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 4.05e-12 | 132 | 89 | 11 | CID000020796 |
| Drug | AC1L1DD6 | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 MMP27 COL1A1 COL1A2 | 5.40e-12 | 179 | 89 | 12 | CID000002299 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 ADCY5 COL1A1 COL1A2 | 1.02e-11 | 189 | 89 | 12 | CID000001413 |
| Drug | foscarnet | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 POLG COL27A1 COL1A1 COL1A2 | 1.09e-11 | 190 | 89 | 12 | CID000003414 |
| Drug | candesartan cilexetil | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 1.14e-11 | 145 | 89 | 11 | CID000002540 |
| Drug | prostacyclin sodium salt | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 NANOS1 ADCY5 COL1A1 COL1A2 | 1.66e-11 | 250 | 89 | 13 | CID000000159 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 3.80e-11 | 162 | 89 | 11 | CID000072363 |
| Drug | khellin | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 6.83e-11 | 171 | 89 | 11 | CID000003828 |
| Drug | AC1Q6PCP | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 RELB COL1A1 COL1A2 | 1.01e-10 | 230 | 89 | 12 | CID000005267 |
| Drug | Collagenase | 2.18e-10 | 4 | 89 | 4 | DB00048 | |
| Drug | (2s,5s)-5-Carboxymethylproline | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 KRT77 COL27A1 TOP3A COL1A1 COL1A2 | 2.80e-10 | 314 | 89 | 13 | CID000447989 |
| Drug | AC1L18QD | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 NANOS1 ADCY5 COL1A1 COL1A2 | 4.27e-10 | 325 | 89 | 13 | CID000000213 |
| Drug | hyaluronan | COL2A1 COL3A1 TSKU COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 4.74e-10 | 263 | 89 | 12 | CID000024759 |
| Drug | silibinin | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 RELB COL1A1 COL1A2 | 1.18e-09 | 285 | 89 | 12 | CID000005213 |
| Drug | desmosine | 1.46e-09 | 53 | 89 | 7 | CID000025435 | |
| Drug | losartan | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 MMP27 NANOS1 COL1A1 COL1A2 | 2.67e-09 | 378 | 89 | 13 | CID000003961 |
| Drug | isodesmosine | 3.06e-09 | 33 | 89 | 6 | CID000013811 | |
| Drug | colchine | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 ECEL1 NANOS1 COL1A1 COL1A2 | 3.13e-09 | 383 | 89 | 13 | CID000002833 |
| Drug | BPAT-143 | 3.25e-09 | 6 | 89 | 4 | CID000146249 | |
| Drug | pyridinoline | 5.07e-09 | 99 | 89 | 8 | CID000105068 | |
| Drug | 351A | 1.21e-08 | 20 | 89 | 5 | CID000122144 | |
| Drug | LS-63783 | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 RNPEP COL21A1 COL27A1 KCNQ1 RELB NANOS1 ADCY5 CIC COL1A1 COL1A2 | 1.22e-08 | 804 | 89 | 17 | CID000000231 |
| Drug | L-3,4-dehydroproline | 1.45e-08 | 73 | 89 | 7 | CID000094284 | |
| Drug | PD123177 | 1.63e-08 | 43 | 89 | 6 | CID000114899 | |
| Drug | aspirin | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 NFKBIB RELB NANOS1 COL1A1 COL1A2 | 3.79e-08 | 563 | 89 | 14 | CID000002244 |
| Drug | Y-27632 | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 NANOS1 COL1A1 COL1A2 | 1.59e-07 | 444 | 89 | 12 | CID000005711 |
| Drug | 4-aminoazobenzene | 2.26e-07 | 66 | 89 | 6 | CID000006051 | |
| Drug | Sirius red | 2.41e-07 | 35 | 89 | 5 | CID005486818 | |
| Drug | ascorbate-2-phosphate | 2.88e-07 | 15 | 89 | 4 | ctd:C011669 | |
| Drug | AC1L1KMJ | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 MARCO COL1A1 COL1A2 | 3.36e-07 | 476 | 89 | 12 | CID000030956 |
| Drug | AC1MRIIV | 4.22e-07 | 39 | 89 | 5 | CID003518584 | |
| Drug | chondroitin sulfate | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 COL1A1 COL1A2 | 6.29e-07 | 413 | 89 | 11 | CID000024766 |
| Drug | NC-4 | 7.85e-07 | 44 | 89 | 5 | CID006420119 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 1.15e-06 | 6 | 89 | 3 | ctd:C502971 | |
| Drug | angiotensin | COL2A1 COL3A1 COL21A1 COL27A1 TM7SF2 RELB NANOS1 ADCY5 COL1A1 | 1.62e-06 | 282 | 89 | 9 | CID003083715 |
| Drug | AC1L9HPX | 1.64e-06 | 92 | 89 | 6 | CID000445279 | |
| Drug | LMWH | COL2A1 COL3A1 COL4A3 COL4A6 COL6A1 COL24A1 COL16A1 COL21A1 COL27A1 KCNQ1 ADCY5 COL1A1 COL1A2 | 1.77e-06 | 663 | 89 | 13 | CID000000772 |
| Drug | deoxypyridinoline | 2.37e-06 | 98 | 89 | 6 | CID000105071 | |
| Drug | dermatan sulfate | 2.41e-06 | 220 | 89 | 8 | CID000032756 | |
| Drug | butylparaben | 2.78e-06 | 157 | 89 | 7 | ctd:C038091 | |
| Drug | trapidil | 2.91e-06 | 57 | 89 | 5 | CID000005531 | |
| Drug | AC1Q641C | 4.42e-06 | 62 | 89 | 5 | CID000005005 | |
| Drug | Rgd Peptide | 4.46e-06 | 239 | 89 | 8 | CID000104802 | |
| Drug | azelastine | 4.77e-06 | 9 | 89 | 3 | ctd:C020976 | |
| Drug | NOC-18 | 9.93e-06 | 73 | 89 | 5 | CID000001606 | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | 1.12e-05 | 194 | 89 | 7 | 3785_UP | |
| Drug | enzacamene | 1.16e-05 | 129 | 89 | 6 | ctd:C038939 | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.23e-05 | 197 | 89 | 7 | 7217_UP | |
| Drug | SB 203580; Down 200; 1uM; PC3; HT_HG-U133A | 1.28e-05 | 198 | 89 | 7 | 7066_DN | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.32e-05 | 199 | 89 | 7 | 4778_UP | |
| Drug | fluoride | 1.34e-05 | 278 | 89 | 8 | CID000014917 | |
| Drug | 5'-methylthioadenosine | 1.51e-05 | 2 | 89 | 2 | ctd:C008500 | |
| Drug | homocystine | 1.75e-05 | 82 | 89 | 5 | CID000010010 | |
| Drug | haloperidol | COL2A1 COL3A1 KLF16 COL21A1 COL27A1 RELB NANOS1 ADCY5 COL1A1 | 2.38e-05 | 394 | 89 | 9 | CID000003559 |
| Drug | Acetaldehyde | 2.59e-05 | 221 | 89 | 7 | ctd:D000079 | |
| Drug | calcium phosphate | 2.64e-05 | 149 | 89 | 6 | CID000024441 | |
| Drug | NOC 18 | 3.12e-05 | 16 | 89 | 3 | ctd:C093285 | |
| Drug | D3273 | 3.40e-05 | 94 | 89 | 5 | CID005464587 | |
| Drug | Hypertensin II | 4.62e-05 | 429 | 89 | 9 | CID000025476 | |
| Drug | Pz-plgpa | 5.35e-05 | 19 | 89 | 3 | CID000152296 | |
| Drug | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | 6.09e-05 | 173 | 89 | 6 | ctd:C063509 | |
| Drug | ramiprilat | 6.39e-05 | 55 | 89 | 4 | CID005464096 | |
| Drug | ALT-711 | 7.30e-05 | 21 | 89 | 3 | CID000216304 | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 8.56e-05 | 184 | 89 | 6 | 2696_UP | |
| Drug | 9,10-epoxy-12-octadecenoic acid | 9.02e-05 | 4 | 89 | 2 | ctd:C051208 | |
| Drug | diacetylrhein | 9.02e-05 | 4 | 89 | 2 | ctd:C025292 | |
| Drug | p-hydroxybestatin | 9.02e-05 | 4 | 89 | 2 | CID000100062 | |
| Drug | 9,10-dihydroxy-12-octadecenoic acid | 9.02e-05 | 4 | 89 | 2 | ctd:C120038 | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 9.08e-05 | 186 | 89 | 6 | 5597_UP | |
| Drug | ethylnylestradiol | COL2A1 COL3A1 COL4A3 RBM12 COL21A1 KRT77 COL27A1 NFKBIB MMP27 RELB NR5A1 NANOS1 ADCY5 COL1A1 COL1A2 | 9.53e-05 | 1251 | 89 | 15 | CID000003285 |
| Drug | AC1L9MJT | 1.08e-04 | 192 | 89 | 6 | CID000448959 | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.14e-04 | 194 | 89 | 6 | 4961_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A | 1.18e-04 | 195 | 89 | 6 | 3802_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; HL60; HT_HG-U133A | 1.18e-04 | 195 | 89 | 6 | 2553_UP | |
| Drug | Cytisine (-) [485-35-8]; Down 200; 21uM; PC3; HT_HG-U133A | 1.18e-04 | 195 | 89 | 6 | 5739_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.18e-04 | 195 | 89 | 6 | 4368_DN | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | 1.18e-04 | 195 | 89 | 6 | 3821_DN | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; PC3; HT_HG-U133A | 1.21e-04 | 196 | 89 | 6 | 5771_UP | |
| Disease | collagen disease (implicated_via_orthology) | 3.43e-08 | 12 | 87 | 4 | DOID:854 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos Syndrome | 2.47e-07 | 5 | 87 | 3 | C0013720 | |
| Disease | Ehlers-Danlos syndrome | 1.37e-06 | 8 | 87 | 3 | cv:C0013720 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 2.05e-06 | 9 | 87 | 3 | DOID:13359 (is_implicated_in) | |
| Disease | Alport syndrome, recessive type | 8.59e-06 | 2 | 87 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 8.59e-06 | 2 | 87 | 2 | C2931253 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 8.59e-06 | 2 | 87 | 2 | C0268345 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 8.59e-06 | 2 | 87 | 2 | C4551623 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 8.59e-06 | 2 | 87 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 8.59e-06 | 2 | 87 | 2 | C0403440 | |
| Disease | Osteogenesis imperfecta with normal sclerae, dominant form | 8.59e-06 | 2 | 87 | 2 | cv:C0268363 | |
| Disease | Osteogenesis imperfecta type III | 8.59e-06 | 2 | 87 | 2 | cv:C0268362 | |
| Disease | Osteogenesis imperfecta, perinatal lethal | 8.59e-06 | 2 | 87 | 2 | cv:C0268358 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE III | 8.59e-06 | 2 | 87 | 2 | 259420 | |
| Disease | osteogenesis imperfecta type 3 (is_implicated_in) | 8.59e-06 | 2 | 87 | 2 | DOID:0110339 (is_implicated_in) | |
| Disease | benign familial hematuria (is_implicated_in) | 8.59e-06 | 2 | 87 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 8.59e-06 | 2 | 87 | 2 | C4746745 | |
| Disease | osteogenesis imperfecta type 4 (is_implicated_in) | 8.59e-06 | 2 | 87 | 2 | DOID:0110340 (is_implicated_in) | |
| Disease | Benign familial hematuria | 8.59e-06 | 2 | 87 | 2 | cv:C0241908 | |
| Disease | osteogenesis imperfecta type 2 (is_implicated_in) | 8.59e-06 | 2 | 87 | 2 | DOID:0110341 (is_implicated_in) | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE IV | 8.59e-06 | 2 | 87 | 2 | 166220 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE II | 8.59e-06 | 2 | 87 | 2 | 166210 | |
| Disease | Fibrosis | 1.46e-05 | 50 | 87 | 4 | C0016059 | |
| Disease | Cirrhosis | 1.46e-05 | 50 | 87 | 4 | C1623038 | |
| Disease | Early Pregnancy Loss | 1.82e-05 | 109 | 87 | 5 | C3830362 | |
| Disease | Spontaneous abortion | 1.82e-05 | 109 | 87 | 5 | C0000786 | |
| Disease | Miscarriage | 1.82e-05 | 109 | 87 | 5 | C4552766 | |
| Disease | Abortion, Tubal | 1.82e-05 | 109 | 87 | 5 | C0000822 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.85e-05 | 53 | 87 | 4 | C4707243 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 2.57e-05 | 3 | 87 | 2 | C4552122 | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 2.57e-05 | 3 | 87 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | osteogenesis imperfecta (is_implicated_in) | 2.57e-05 | 3 | 87 | 2 | DOID:12347 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 3 (implicated_via_orthology) | 2.57e-05 | 3 | 87 | 2 | DOID:0110339 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 2.57e-05 | 3 | 87 | 2 | C0220679 | |
| Disease | Alport syndrome | 2.57e-05 | 3 | 87 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 2.57e-05 | 3 | 87 | 2 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 5.14e-05 | 4 | 87 | 2 | C0241908 | |
| Disease | OSTEOPOROSIS | 5.14e-05 | 4 | 87 | 2 | 166710 | |
| Disease | Alport Syndrome | 5.14e-05 | 4 | 87 | 2 | C1567741 | |
| Disease | Osteogenesis imperfecta, dominant perinatal lethal | 8.54e-05 | 5 | 87 | 2 | C0268358 | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 8.54e-05 | 5 | 87 | 2 | DOID:12347 (implicated_via_orthology) | |
| Disease | Lobstein Disease | 8.54e-05 | 5 | 87 | 2 | C0023931 | |
| Disease | Alport Syndrome, X-Linked | 8.54e-05 | 5 | 87 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 8.54e-05 | 5 | 87 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 8.54e-05 | 5 | 87 | 2 | C1567744 | |
| Disease | Osteoporosis | 1.28e-04 | 6 | 87 | 2 | cv:C0029456 | |
| Disease | hypertensive nephropathy | 1.28e-04 | 6 | 87 | 2 | C0848548 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 1.28e-04 | 6 | 87 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 1.79e-04 | 7 | 87 | 2 | C1846545 | |
| Disease | Bleeding tendency | 1.79e-04 | 7 | 87 | 2 | C1458140 | |
| Disease | end stage renal disease (is_implicated_in) | 2.43e-04 | 41 | 87 | 3 | DOID:783 (is_implicated_in) | |
| Disease | Liver Cirrhosis | 2.50e-04 | 103 | 87 | 4 | C0023890 | |
| Disease | Fibrosis, Liver | 2.69e-04 | 105 | 87 | 4 | C0239946 | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 3.05e-04 | 9 | 87 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 3.81e-04 | 10 | 87 | 2 | C0268363 | |
| Disease | myopathy (implicated_via_orthology) | 3.89e-04 | 48 | 87 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Male sterility | 3.89e-04 | 48 | 87 | 3 | C0917731 | |
| Disease | Male infertility | 3.89e-04 | 48 | 87 | 3 | C0021364 | |
| Disease | Subfertility, Male | 3.89e-04 | 48 | 87 | 3 | C0848676 | |
| Disease | colorectal cancer | 4.16e-04 | 604 | 87 | 8 | MONDO_0005575 | |
| Disease | Nephrosclerosis | 4.65e-04 | 11 | 87 | 2 | C0027719 | |
| Disease | Semantic-Pragmatic Disorder | 4.65e-04 | 11 | 87 | 2 | C0454655 | |
| Disease | Microphthalmos | 4.65e-04 | 11 | 87 | 2 | C0026010 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 4.65e-04 | 11 | 87 | 2 | C0268362 | |
| Disease | Aortic Valve Insufficiency | 4.65e-04 | 11 | 87 | 2 | C0003504 | |
| Disease | Auditory Processing Disorder, Central | 4.65e-04 | 11 | 87 | 2 | C0751257 | |
| Disease | Language Delay | 4.65e-04 | 11 | 87 | 2 | C0023012 | |
| Disease | Language Development Disorders | 4.65e-04 | 11 | 87 | 2 | C0023014 | |
| Disease | Speech Delay | 4.65e-04 | 11 | 87 | 2 | C0241210 | |
| Disease | intracranial aneurysm (is_implicated_in) | 5.56e-04 | 12 | 87 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 5.56e-04 | 12 | 87 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | factor VII measurement | 5.81e-04 | 55 | 87 | 3 | EFO_0004619 | |
| Disease | Osteogenesis Imperfecta | 6.56e-04 | 13 | 87 | 2 | C0029434 | |
| Disease | body weights and measures, parental genotype effect measurement | 7.64e-04 | 14 | 87 | 2 | EFO_0004324, EFO_0005939 | |
| Disease | familial atrial fibrillation (is_implicated_in) | 7.64e-04 | 14 | 87 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | Post-Traumatic Osteoporosis | 7.87e-04 | 61 | 87 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 7.87e-04 | 61 | 87 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 7.87e-04 | 61 | 87 | 3 | C0001787 | |
| Disease | Cerebrovascular accident | 8.26e-04 | 62 | 87 | 3 | C0038454 | |
| Disease | Osteoporosis | 8.65e-04 | 63 | 87 | 3 | C0029456 | |
| Disease | hepcidin:transferrin saturation ratio | 8.80e-04 | 15 | 87 | 2 | EFO_0007902 | |
| Disease | Hereditary hearing loss and deafness | 9.31e-04 | 146 | 87 | 4 | cv:C0236038 | |
| Disease | Blood Coagulation Disorders | 1.00e-03 | 16 | 87 | 2 | C0005779 | |
| Disease | colorectal cancer, colorectal adenoma | 1.08e-03 | 152 | 87 | 4 | EFO_0005406, MONDO_0005575 | |
| Disease | plasma beta-amyloid 1-40 measurement | 1.14e-03 | 17 | 87 | 2 | EFO_0005659 | |
| Disease | Oral Submucous Fibrosis | 1.28e-03 | 18 | 87 | 2 | C0029172 | |
| Disease | Schizophrenia | 1.28e-03 | 18 | 87 | 2 | cv:C0036341 | |
| Disease | Osteogenesis imperfecta | 1.74e-03 | 21 | 87 | 2 | cv:C0029434 | |
| Disease | age at menarche | 1.88e-03 | 594 | 87 | 7 | EFO_0004703 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 1.91e-03 | 22 | 87 | 2 | C1843687 | |
| Disease | platelet crit | 1.97e-03 | 952 | 87 | 9 | EFO_0007985 | |
| Disease | Renal glomerular disease | 2.09e-03 | 23 | 87 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.09e-03 | 23 | 87 | 2 | C4521256 | |
| Disease | Headache, type 2 diabetes mellitus | 2.09e-03 | 23 | 87 | 2 | HP_0002315, MONDO_0005148 | |
| Disease | Left Ventricular Hypertrophy | 2.47e-03 | 25 | 87 | 2 | C0149721 | |
| Disease | intestinal permeability measurement | 2.67e-03 | 26 | 87 | 2 | EFO_0011031 | |
| Disease | Heart valve disease | 2.67e-03 | 26 | 87 | 2 | C0018824 | |
| Disease | Squamous cell carcinoma of esophagus | 2.82e-03 | 95 | 87 | 3 | C0279626 | |
| Disease | Nephrotic Syndrome | 2.88e-03 | 27 | 87 | 2 | C0027726 | |
| Disease | glucose tolerance test | 2.88e-03 | 27 | 87 | 2 | EFO_0004307 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGGLAEGAGALAPPP | 406 | P50548 | |
| GAVGFPGPDGYPGLL | 131 | Q14031 | |
| LPGLPGDGGQGFPGE | 586 | Q14031 | |
| GDVGLPGAPGFPGVA | 1121 | Q14031 | |
| GFPGFPGLHGLNGLP | 1166 | Q14031 | |
| RGFPGLQGPAGLPGA | 1231 | Q14031 | |
| LDLRAEFGPPGPGAG | 41 | Q9H4A4 | |
| EFGPPGPGAGSRGLS | 46 | Q9H4A4 | |
| GGPPLGPFADGALDR | 151 | O00192 | |
| GADPKPGPFGGGLAL | 51 | Q7RTU5 | |
| PGPFGGGLALGPAPR | 56 | Q7RTU5 | |
| LPGFPGFPGAQGDPG | 521 | Q01955 | |
| GLPGPRGDPGFQGFP | 1301 | Q01955 | |
| LGGEAGGPAAGPLAP | 216 | O14514 | |
| YPPALGSPGALAGAG | 231 | Q96IF1 | |
| GDVGSPGFGLPGLPG | 576 | Q07092 | |
| PFGRAGAPGPGGGSD | 541 | Q13202 | |
| AARGYGTPGPGGDLP | 36 | Q8NDY6 | |
| PGAEGPAGIPGFLGL | 791 | P53420 | |
| GPPGPDGFLFGLKGA | 441 | P08572 | |
| KGRAGFPGLPGSPGA | 456 | P08572 | |
| PGLPGPKGFAGINGE | 496 | P08572 | |
| SPGRDGLDGFPGLPG | 576 | P08572 | |
| IPGFAGADGGPGPRG | 706 | P08572 | |
| PPLSGDDPLAGGFGF | 81 | O95622 | |
| LLGGFQSLGGPGEPG | 481 | Q69YU3 | |
| SAGAPGIAGAPGFPG | 421 | P02458 | |
| GFPGQDGLAGPKGAP | 516 | P02458 | |
| ALAGPLGGALGVPGA | 211 | O95158 | |
| PIPPPGLGGGAFGDA | 736 | Q9NTZ6 | |
| NFGNGPGSLGGPPGF | 791 | Q9NTZ6 | |
| GLGSAPGHLGGPPAF | 811 | Q9NTZ6 | |
| DGKPCLGPGPGAPAF | 216 | A6NCS4 | |
| PGAGFPFAFPGALRG | 21 | P13631 | |
| FGLDGGQPGPGEGLP | 66 | Q01201 | |
| LGVLGHAFPPGPGLG | 176 | Q9H306 | |
| AGGALYAPIAPGAPG | 46 | P51787 | |
| DLRGGPGAAPGGASP | 86 | Q9BXK1 | |
| EGPGAAPAFAGPGGG | 1381 | Q86UL8 | |
| AAGALAGLGGLPGVP | 621 | Q14526 | |
| PGPLLGAPGGLAGAD | 71 | Q6ZQN5 | |
| GPGDGNLGYQLGPPA | 296 | O43593 | |
| LGSLGPDAAAPGGPG | 21 | Q15653 | |
| PDAAAPGGPGLGAEL | 26 | Q15653 | |
| PGGPGLGAELGPGLS | 31 | Q15653 | |
| AGPGALGPALGPPDY | 91 | Q8WY41 | |
| GPGSGPLGEPLADGL | 256 | Q13608 | |
| GPGPPFALGCGGAAR | 101 | Q9NP08 | |
| PGHAAAFGGPPGGLL | 396 | A8MYZ6 | |
| FGGPPASPGGFPLEG | 2111 | Q9UM47 | |
| TPGVLLPGAGGAAGF | 286 | Q6ZTU2 | |
| ALTPGLGAEAGGGFP | 66 | Q9Y5B6 | |
| GLLGPAGLAGVGAFP | 251 | Q9UNW9 | |
| AGEAGAGPAGGAAPP | 331 | Q9UNW9 | |
| GGARGASLPPGFPLG | 26 | O95672 | |
| GPRAPLEFGGPLGAA | 6 | O76062 | |
| DFGEQPFGGSGPGPG | 56 | P09016 | |
| GPLGGGRYALPGGSP | 181 | Q2TBC4 | |
| AGFPPGAVAGGGAGP | 96 | Q58A45 | |
| AAGLPGVAGAPGLPG | 311 | P08123 | |
| DGPAGNGTEGFPGFP | 511 | P12109 | |
| FGPFRGEGPGPNGLP | 641 | Q9BQN1 | |
| PGFCGPLAPGTGGPF | 3076 | Q9Y6R7 | |
| GGGGDFDYPGAPAGP | 101 | P49715 | |
| PGFSEGPGFLGGEGP | 576 | Q53ET0 | |
| DPGELGSGGGPSAPF | 336 | P26992 | |
| SGFLAGGRPPGEPGG | 271 | O95886 | |
| PLPPAALGAYSGGAG | 66 | Q9NX05 | |
| KGNAGFPGLPGPAGE | 556 | Q96P44 | |
| AGSPGARGFPGAPGL | 281 | P05997 | |
| AGNDGARGLPGPLGP | 791 | P05997 | |
| FPGVFGERGPPGLDG | 791 | Q8IZC6 | |
| DFGRPGPPGLAGFPG | 281 | Q9UEW3 | |
| GPPGLAGFPGAKGDQ | 286 | Q9UEW3 | |
| GGLLPEGGGEAPAPA | 306 | Q96SL8 | |
| AGGPGGAALGEAPPG | 56 | Q6UW01 | |
| PGLAGAPGLRGGAGP | 686 | P02461 | |
| PGGPGAAGFPGARGL | 866 | P02461 | |
| AAGFPGARGLPGPPG | 871 | P02461 | |
| GGPGSGPFADLAPGA | 21 | Q9BUL9 | |
| VAGPAAPEAPGLGLG | 176 | A0A3B3IS91 | |
| APEAPGLGLGGGLDP | 181 | A0A3B3IS91 | |
| AGPAALAARAGPGPG | 161 | O00268 | |
| FEAELLSPPGPGGGG | 46 | Q4G112 | |
| APGDGGEAPPAAGLG | 41 | Q8N1G1 | |
| LPPGAGAGPGGGAMF | 446 | P84550 | |
| GLAAGPPAGPLGDFG | 151 | Q13285 | |
| GPLPGLGFAPGLAGQ | 496 | O15119 | |
| GPAGFKAPALGGLGA | 36 | Q9C056 | |
| AGPGPGAGAGAAAEP | 66 | Q6DKJ4 | |
| ALGLGEPEGSGLPPG | 71 | Q6P5W5 | |
| AAPGGARFGPGAGPV | 246 | A1L4H1 | |
| AGGFPLPPLSPGGGA | 6 | Q92925 | |
| GAPGPFAAPGEGGAL | 396 | Q96RK0 | |
| PFGAPAGAPGGPALG | 6 | P09496 | |
| GAPGIAGAPGFPGAR | 401 | P02452 | |
| DAGAKGDAGPPGPAG | 831 | P02452 | |
| GLPGLPGEQGIPGFA | 576 | Q17RW2 | |
| GPGPEALGFVGDAGP | 151 | Q8IZ63 | |
| LPEPGGALAGGPGSG | 81 | Q6YI46 | |
| GGPAGLAAPDLGDFP | 76 | Q9NUD5 | |
| GPGPATFAGFLGRDP | 46 | Q9H2W2 | |
| GPRPGGLDYGAGDGP | 991 | Q9BYB0 | |
| AGDGPGLAFGGPGPA | 1001 | Q9BYB0 | |
| GLPPLGAADGALGPG | 666 | Q6T4P5 | |
| FPLQPGSYPAGGGAG | 776 | Q96JE7 | |
| RGPDGASYLGGPPGG | 36 | O43711 | |
| LGCPPGPGIHLGGFG | 871 | Q13472 | |
| GVAGGFGAGPPLARP | 241 | Q5TEC3 | |
| PLAVIGPGAFAGLGG | 216 | Q8WUA8 | |
| NFGLGGFGPYCPPGG | 121 | Q7Z794 | |
| AGGFPAALPAGPAGE | 2491 | O14686 | |
| APGELGGLGPGPAEA | 291 | Q9UPR5 |